{"entity":"stryker","name":"Stryker Corporation","kind":null,"summary":"Stryker Corporation's timeline holds 599 claims from 2006 to 2026: 1 people, 589 money & deals, 9 other. 9 are undated. The latest took effect on September 30, 2026.","counts":{"total":599,"by_kind":{"people":1,"money":589,"products":0,"models":0,"other":9}},"events":[{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation sic industry: Surgical & Medical Instruments & Apparatus (3841)\", undated. Claim clm_123EE85DCB44, https://asof.is/claim/clm_123EE85DCB44, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310764.","url":"https://asof.is/claim/clm_123EE85DCB44","accessed":"2026-11-10"},"kind":"other","predicate":"sic_industry","value":"Surgical & Medical Instruments & Apparatus (3841)","status":"valid","assertable":true,"id":"clm_123EE85DCB44","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation state of incorporation: MI\", undated. Claim clm_159EC169C13E, https://asof.is/claim/clm_159EC169C13E, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310764.","url":"https://asof.is/claim/clm_159EC169C13E","accessed":"2026-11-10"},"kind":"other","predicate":"state_of_incorporation","value":"MI","status":"valid","assertable":true,"id":"clm_159EC169C13E","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation registrant name: STRYKER CORP\", undated. Claim clm_4627F7A3346E, https://asof.is/claim/clm_4627F7A3346E, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310764.","url":"https://asof.is/claim/clm_4627F7A3346E","accessed":"2026-11-10"},"kind":"other","predicate":"registrant_name","value":"STRYKER CORP","status":"valid","assertable":true,"id":"clm_4627F7A3346E","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation ticker: SYK\", undated. Claim clm_478EDB1FE143, https://asof.is/claim/clm_478EDB1FE143, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310764.","url":"https://asof.is/claim/clm_478EDB1FE143","accessed":"2026-11-10"},"kind":"other","predicate":"ticker","value":"SYK","status":"valid","assertable":true,"id":"clm_478EDB1FE143","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cfo: Preston W. Wells\", undated. Claim clm_7046BA56C083, https://asof.is/claim/clm_7046BA56C083, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/syk-20251231.htm.","url":"https://asof.is/claim/clm_7046BA56C083","accessed":"2026-11-10"},"kind":"people","predicate":"cfo","value":"Preston W. Wells","status":"valid","assertable":true,"id":"clm_7046BA56C083","evidence":{"by":"page-read","on":"2026-11-09","quote":"Preston W. Wells 49 Vice President, Chief Financial Officer 2025","url":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/syk-20251231.htm"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cik: 0000310764\", undated. Claim clm_8567D7D06C42, https://asof.is/claim/clm_8567D7D06C42, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310764.","url":"https://asof.is/claim/clm_8567D7D06C42","accessed":"2026-11-10"},"kind":"other","predicate":"cik","value":"0000310764","status":"valid","assertable":true,"id":"clm_8567D7D06C42","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation listed on: NYSE\", undated. Claim clm_A90074F54C24, https://asof.is/claim/clm_A90074F54C24, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310764.","url":"https://asof.is/claim/clm_A90074F54C24","accessed":"2026-11-10"},"kind":"other","predicate":"listed_on","value":"NYSE","status":"valid","assertable":true,"id":"clm_A90074F54C24","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation fiscal year end: 12-31\", undated. Claim clm_E2EF73B2747F, https://asof.is/claim/clm_E2EF73B2747F, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310764.","url":"https://asof.is/claim/clm_E2EF73B2747F","accessed":"2026-11-10"},"kind":"other","predicate":"fiscal_year_end","value":"12-31","status":"valid","assertable":true,"id":"clm_E2EF73B2747F","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation website: https://stryker.com\", undated. Claim clm_93ACF2DD5C7E, https://asof.is/claim/clm_93ACF2DD5C7E, accessed 2026-11-10. Source: https://www.wikidata.org/wiki/Q2357515.","url":"https://asof.is/claim/clm_93ACF2DD5C7E","accessed":"2026-11-10"},"kind":"other","predicate":"website","value":"https://stryker.com","status":"unverified","assertable":false,"why_not":"low_confidence","id":"clm_93ACF2DD5C7E","evidence":{"by":"own-site","on":"2026-11-08","quote":"International homepage | Stryker.","url":"https://www.stryker.com/"}},{"date":"2006-12-31","until":"2007-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 4,191,000,000 United States dollar\", as of 2006-12-31 (until 2007-12-31). Claim clm_AF9FF365F979, https://asof.is/claim/clm_AF9FF365F979, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_AF9FF365F979","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"4,191,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AF9FF365F979","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-26"}},{"date":"2006-12-31","until":"2007-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 416,600,000 United States dollar\", as of 2006-12-31 (until 2007-12-31). Claim clm_F770CAB41FDC, https://asof.is/claim/clm_F770CAB41FDC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_F770CAB41FDC","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"416,600,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F770CAB41FDC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"date":"2007-12-31","until":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 375,300,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_295A66A8882F, https://asof.is/claim/clm_295A66A8882F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_295A66A8882F","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"375,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_295A66A8882F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2009, filed 2010-02-26"}},{"date":"2007-12-31","until":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 5,378,500,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_69406B57602F, https://asof.is/claim/clm_69406B57602F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_69406B57602F","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"5,378,500,000 United States dollar","status":"superseded","assertable":true,"id":"clm_69406B57602F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-26"}},{"date":"2007-12-31","until":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 1,307,300,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_75486CA17271, https://asof.is/claim/clm_75486CA17271, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_75486CA17271","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"1,307,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_75486CA17271","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"date":"2007-12-31","until":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 6,000,500,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_B62204F28676, https://asof.is/claim/clm_B62204F28676, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_B62204F28676","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"6,000,500,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B62204F28676","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2009, filed 2010-02-26"}},{"date":"2007-12-31","until":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 1,017,400,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_BF11F68A601C, https://asof.is/claim/clm_BF11F68A601C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_BF11F68A601C","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"1,017,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BF11F68A601C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"date":"2007-12-31","until":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 290,500,000 United States dollar\", as of 2007-12-31 (until 2008-12-31). Claim clm_DAEA8CC5073D, https://asof.is/claim/clm_DAEA8CC5073D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_DAEA8CC5073D","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"290,500,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DAEA8CC5073D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"date":"2008-06-30","until":"2008-09-30","published":"2009-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 1,712,600,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_1A3BD4C5AC92, https://asof.is/claim/clm_1A3BD4C5AC92, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509186885/0001193125-09-186885-index.htm.","url":"https://asof.is/claim/clm_1A3BD4C5AC92","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"1,712,600,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1A3BD4C5AC92","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q/A Q2 FY2009, filed 2009-09-03"}},{"date":"2008-06-30","until":"2008-09-30","published":"2009-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 305,800,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_28FD7932884B, https://asof.is/claim/clm_28FD7932884B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509186885/0001193125-09-186885-index.htm.","url":"https://asof.is/claim/clm_28FD7932884B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"305,800,000 United States dollar","status":"superseded","assertable":true,"id":"clm_28FD7932884B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q/A Q2 FY2009, filed 2009-09-03"}},{"date":"2008-06-30","until":"2008-09-30","published":"2009-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 400,900,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_B80F2C2FA315, https://asof.is/claim/clm_B80F2C2FA315, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509186885/0001193125-09-186885-index.htm.","url":"https://asof.is/claim/clm_B80F2C2FA315","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"400,900,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B80F2C2FA315","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q/A Q2 FY2009, filed 2009-09-03"}},{"date":"2008-06-30","until":"2008-09-30","published":"2009-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 90,300,000 United States dollar\", as of 2008-06-30 (until 2008-09-30). Claim clm_C4D2A72089DC, https://asof.is/claim/clm_C4D2A72089DC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509186885/0001193125-09-186885-index.htm.","url":"https://asof.is/claim/clm_C4D2A72089DC","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"90,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C4D2A72089DC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q/A Q2 FY2009, filed 2009-09-03"}},{"date":"2008-09-30","until":"2009-03-31","published":"2009-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 92,600,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_10BC8BB0CDC0, https://asof.is/claim/clm_10BC8BB0CDC0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509229142/0001193125-09-229142-index.htm.","url":"https://asof.is/claim/clm_10BC8BB0CDC0","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"92,600,000 United States dollar","status":"superseded","assertable":true,"id":"clm_10BC8BB0CDC0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2009, filed 2009-11-09"}},{"date":"2008-09-30","until":"2009-03-31","published":"2009-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 273,800,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_147721F941E8, https://asof.is/claim/clm_147721F941E8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509229142/0001193125-09-229142-index.htm.","url":"https://asof.is/claim/clm_147721F941E8","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"273,800,000 United States dollar","status":"superseded","assertable":true,"id":"clm_147721F941E8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-09"}},{"date":"2008-09-30","until":"2009-03-31","published":"2009-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 364,100,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_A74EC52E97FE, https://asof.is/claim/clm_A74EC52E97FE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509229142/0001193125-09-229142-index.htm.","url":"https://asof.is/claim/clm_A74EC52E97FE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"364,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A74EC52E97FE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-09"}},{"date":"2008-09-30","until":"2009-03-31","published":"2009-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 1,653,000,000 United States dollar\", as of 2008-09-30 (until 2009-03-31). Claim clm_D56567958C98, https://asof.is/claim/clm_D56567958C98, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509229142/0001193125-09-229142-index.htm.","url":"https://asof.is/claim/clm_D56567958C98","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"1,653,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D56567958C98","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2009, filed 2009-11-09"}},{"date":"2008-12-31","until":"2009-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 1,519,000,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_224CD9F897E9, https://asof.is/claim/clm_224CD9F897E9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_224CD9F897E9","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"1,519,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_224CD9F897E9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"date":"2008-12-31","until":"2009-06-30","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 701,100,000 United States dollar\", as of 2008-12-31 (until 2009-06-30). Claim clm_299A838D5950, https://asof.is/claim/clm_299A838D5950, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_299A838D5950","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"701,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_299A838D5950","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"date":"2008-12-31","until":"2009-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 6,718,200,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_629A9E88905C, https://asof.is/claim/clm_629A9E88905C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_629A9E88905C","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"6,718,200,000 United States dollar","status":"superseded","assertable":true,"id":"clm_629A9E88905C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2009, filed 2010-02-26"}},{"date":"2008-12-31","until":"2009-06-30","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 7,603,300,000 United States dollar\", as of 2008-12-31 (until 2009-06-30). Claim clm_6E2B9A6171F9, https://asof.is/claim/clm_6E2B9A6171F9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_6E2B9A6171F9","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"7,603,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6E2B9A6171F9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-02-26"}},{"date":"2008-12-31","until":"2009-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 367,800,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_AA8CC59B01C5, https://asof.is/claim/clm_AA8CC59B01C5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_AA8CC59B01C5","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"367,800,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AA8CC59B01C5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2009, filed 2010-02-26"}},{"date":"2008-12-31","until":"2009-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 1,147,800,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_C3CE15157F07, https://asof.is/claim/clm_C3CE15157F07, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_C3CE15157F07","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"1,147,800,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C3CE15157F07","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"date":"2008-12-31","until":"2009-06-30","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 5,406,700,000 United States dollar\", as of 2008-12-31 (until 2009-06-30). Claim clm_DA10B9583E76, https://asof.is/claim/clm_DA10B9583E76, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_DA10B9583E76","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"5,406,700,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DA10B9583E76","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-26"}},{"date":"2009-03-31","until":"2009-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 80,400,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_5D085B88D37F, https://asof.is/claim/clm_5D085B88D37F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510098095/0001193125-10-098095-index.htm.","url":"https://asof.is/claim/clm_5D085B88D37F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"80,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5D085B88D37F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2009-03-31","until":"2009-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 379,200,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_9AD62A6BB17B, https://asof.is/claim/clm_9AD62A6BB17B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510098095/0001193125-10-098095-index.htm.","url":"https://asof.is/claim/clm_9AD62A6BB17B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"379,200,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9AD62A6BB17B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2009-03-31","until":"2009-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 1,601,300,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_F9DB51B074FD, https://asof.is/claim/clm_F9DB51B074FD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510098095/0001193125-10-098095-index.htm.","url":"https://asof.is/claim/clm_F9DB51B074FD","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"1,601,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F9DB51B074FD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2009-03-31","until":"2009-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 281,100,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_FDC9598AC3EC, https://asof.is/claim/clm_FDC9598AC3EC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510098095/0001193125-10-098095-index.htm.","url":"https://asof.is/claim/clm_FDC9598AC3EC","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"281,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FDC9598AC3EC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 666,300,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_517D8386F06F, https://asof.is/claim/clm_517D8386F06F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509186885/0001193125-09-186885-index.htm.","url":"https://asof.is/claim/clm_517D8386F06F","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"666,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_517D8386F06F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q/A Q2 FY2009, filed 2009-09-03"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 389,800,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_67A2A5CDB5F0, https://asof.is/claim/clm_67A2A5CDB5F0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509186885/0001193125-09-186885-index.htm.","url":"https://asof.is/claim/clm_67A2A5CDB5F0","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"389,800,000 United States dollar","status":"superseded","assertable":true,"id":"clm_67A2A5CDB5F0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q/A Q2 FY2009, filed 2009-09-03"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 7,923,500,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_9956441B013A, https://asof.is/claim/clm_9956441B013A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509186885/0001193125-09-186885-index.htm.","url":"https://asof.is/claim/clm_9956441B013A","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"7,923,500,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9956441B013A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q/A Q2 FY2009, filed 2009-09-03"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 1,634,300,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_B0AE32FA5091, https://asof.is/claim/clm_B0AE32FA5091, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509186885/0001193125-09-186885-index.htm.","url":"https://asof.is/claim/clm_B0AE32FA5091","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"1,634,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B0AE32FA5091","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q/A Q2 FY2009, filed 2009-09-03"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 6,057,500,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_CC58F9B2FE3A, https://asof.is/claim/clm_CC58F9B2FE3A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509186885/0001193125-09-186885-index.htm.","url":"https://asof.is/claim/clm_CC58F9B2FE3A","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"6,057,500,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CC58F9B2FE3A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q/A Q2 FY2009, filed 2009-09-03"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 291,300,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_D55A2499EA2F, https://asof.is/claim/clm_D55A2499EA2F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509186885/0001193125-09-186885-index.htm.","url":"https://asof.is/claim/clm_D55A2499EA2F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"291,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D55A2499EA2F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q/A Q2 FY2009, filed 2009-09-03"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 82,600,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_DC9C02DB3BFB, https://asof.is/claim/clm_DC9C02DB3BFB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509186885/0001193125-09-186885-index.htm.","url":"https://asof.is/claim/clm_DC9C02DB3BFB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"82,600,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DC9C02DB3BFB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q/A Q2 FY2009, filed 2009-09-03"}},{"date":"2009-07-31","until":"2009-10-31","published":"2009-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 397,547,322 shares\", as of 2009-07-31 (until 2009-10-31). Claim clm_CDF95198330D, https://asof.is/claim/clm_CDF95198330D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509186885/0001193125-09-186885-index.htm.","url":"https://asof.is/claim/clm_CDF95198330D","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"397,547,322 shares","status":"superseded","assertable":true,"id":"clm_CDF95198330D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q/A Q2 FY2009, filed 2009-09-03"}},{"date":"2009-09-30","until":"2009-12-31","published":"2009-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 6,440,900,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_4049D2203338, https://asof.is/claim/clm_4049D2203338, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509229142/0001193125-09-229142-index.htm.","url":"https://asof.is/claim/clm_4049D2203338","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"6,440,900,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4049D2203338","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2009, filed 2009-11-09"}},{"date":"2009-09-30","until":"2010-03-31","published":"2009-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 311,400,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_405256E3976D, https://asof.is/claim/clm_405256E3976D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509229142/0001193125-09-229142-index.htm.","url":"https://asof.is/claim/clm_405256E3976D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"311,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_405256E3976D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-09"}},{"date":"2009-09-30","until":"2010-03-31","published":"2009-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 83,700,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_4C296F1D3D42, https://asof.is/claim/clm_4C296F1D3D42, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509229142/0001193125-09-229142-index.htm.","url":"https://asof.is/claim/clm_4C296F1D3D42","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"83,700,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4C296F1D3D42","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2009, filed 2009-11-09"}},{"date":"2009-09-30","until":"2010-03-31","published":"2009-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 229,000,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_6FA66BDED22E, https://asof.is/claim/clm_6FA66BDED22E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509229142/0001193125-09-229142-index.htm.","url":"https://asof.is/claim/clm_6FA66BDED22E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"229,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6FA66BDED22E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-09"}},{"date":"2009-09-30","until":"2009-12-31","published":"2009-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 960,300,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_846FE8113B18, https://asof.is/claim/clm_846FE8113B18, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509229142/0001193125-09-229142-index.htm.","url":"https://asof.is/claim/clm_846FE8113B18","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"960,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_846FE8113B18","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2009, filed 2009-11-09"}},{"date":"2009-09-30","until":"2010-03-31","published":"2009-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 1,653,300,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_A36055955964, https://asof.is/claim/clm_A36055955964, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509229142/0001193125-09-229142-index.htm.","url":"https://asof.is/claim/clm_A36055955964","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"1,653,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A36055955964","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2009, filed 2009-11-09"}},{"date":"2009-09-30","until":"2009-12-31","published":"2009-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 8,459,200,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_F34DEB6BFAE6, https://asof.is/claim/clm_F34DEB6BFAE6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509229142/0001193125-09-229142-index.htm.","url":"https://asof.is/claim/clm_F34DEB6BFAE6","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"8,459,200,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F34DEB6BFAE6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2009, filed 2009-11-09"}},{"date":"2009-10-31","until":"2010-01-31","published":"2009-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 397,738,563 shares\", as of 2009-10-31 (until 2010-01-31). Claim clm_6892602211C3, https://asof.is/claim/clm_6892602211C3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312509229142/0001193125-09-229142-index.htm.","url":"https://asof.is/claim/clm_6892602211C3","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"397,738,563 shares","status":"superseded","assertable":true,"id":"clm_6892602211C3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2009, filed 2009-11-09"}},{"date":"2009-12-31","until":"2010-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 6,595,100,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_2E964C13FF0F, https://asof.is/claim/clm_2E964C13FF0F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_2E964C13FF0F","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"6,595,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2E964C13FF0F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-26"}},{"date":"2009-12-31","until":"2010-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 658,700,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_743E7A9DCCFC, https://asof.is/claim/clm_743E7A9DCCFC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_743E7A9DCCFC","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"658,700,000 United States dollar","status":"superseded","assertable":true,"id":"clm_743E7A9DCCFC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"date":"2009-12-31","until":"2010-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 9,071,300,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_906BE0D4F7FB, https://asof.is/claim/clm_906BE0D4F7FB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_906BE0D4F7FB","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"9,071,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_906BE0D4F7FB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-02-26"}},{"date":"2009-12-31","until":"2010-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 6,723,100,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_9D906633D7D7, https://asof.is/claim/clm_9D906633D7D7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_9D906633D7D7","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"6,723,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9D906633D7D7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2009, filed 2010-02-26"}},{"date":"2009-12-31","until":"2010-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 1,594,400,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_C28150582E16, https://asof.is/claim/clm_C28150582E16, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_C28150582E16","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"1,594,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C28150582E16","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"date":"2009-12-31","until":"2010-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 336,200,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_CCC592E32CE7, https://asof.is/claim/clm_CCC592E32CE7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_CCC592E32CE7","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"336,200,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CCC592E32CE7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2009, filed 2010-02-26"}},{"date":"2009-12-31","until":"2010-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 1,107,400,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_EC17B9F0CE3D, https://asof.is/claim/clm_EC17B9F0CE3D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_EC17B9F0CE3D","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"1,107,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EC17B9F0CE3D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"date":"2010-01-31","until":"2010-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 398,051,370 shares\", as of 2010-01-31 (until 2010-03-31). Claim clm_E2448CD4BFA2, https://asof.is/claim/clm_E2448CD4BFA2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510042997/0001193125-10-042997-index.htm.","url":"https://asof.is/claim/clm_E2448CD4BFA2","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"398,051,370 shares","status":"superseded","assertable":true,"id":"clm_E2448CD4BFA2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2009, filed 2010-02-26"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 446,400,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_2C7008B8AD14, https://asof.is/claim/clm_2C7008B8AD14, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510098095/0001193125-10-098095-index.htm.","url":"https://asof.is/claim/clm_2C7008B8AD14","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"446,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2C7008B8AD14","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 321,700,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_3A644C92BA66, https://asof.is/claim/clm_3A644C92BA66, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510098095/0001193125-10-098095-index.htm.","url":"https://asof.is/claim/clm_3A644C92BA66","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"321,700,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3A644C92BA66","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 90,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_453589D6EA57, https://asof.is/claim/clm_453589D6EA57, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510098095/0001193125-10-098095-index.htm.","url":"https://asof.is/claim/clm_453589D6EA57","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"90,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_453589D6EA57","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2010-03-31","until":"2010-07-31","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 396,698,933 shares\", as of 2010-03-31 (until 2010-07-31). Claim clm_60F6C32EDB5A, https://asof.is/claim/clm_60F6C32EDB5A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510098095/0001193125-10-098095-index.htm.","url":"https://asof.is/claim/clm_60F6C32EDB5A","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"396,698,933 shares","status":"superseded","assertable":true,"id":"clm_60F6C32EDB5A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 10,098,400,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_79DB9D887661, https://asof.is/claim/clm_79DB9D887661, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510098095/0001193125-10-098095-index.htm.","url":"https://asof.is/claim/clm_79DB9D887661","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"10,098,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_79DB9D887661","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 6,670,800,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_92CF0B698262, https://asof.is/claim/clm_92CF0B698262, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510098095/0001193125-10-098095-index.htm.","url":"https://asof.is/claim/clm_92CF0B698262","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"6,670,800,000 United States dollar","status":"superseded","assertable":true,"id":"clm_92CF0B698262","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 1,799,100,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_A0ED8BED298A, https://asof.is/claim/clm_A0ED8BED298A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510098095/0001193125-10-098095-index.htm.","url":"https://asof.is/claim/clm_A0ED8BED298A","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"1,799,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A0ED8BED298A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,202,500,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_FD83B8699239, https://asof.is/claim/clm_FD83B8699239, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510098095/0001193125-10-098095-index.htm.","url":"https://asof.is/claim/clm_FD83B8699239","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,202,500,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FD83B8699239","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2010, filed 2010-04-29"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 785,200,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_361E4D24E38B, https://asof.is/claim/clm_361E4D24E38B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510182697/0001193125-10-182697-index.htm.","url":"https://asof.is/claim/clm_361E4D24E38B","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"785,200,000 United States dollar","status":"superseded","assertable":true,"id":"clm_361E4D24E38B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2010, filed 2010-08-09"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 94,600,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_4242495E8AAB, https://asof.is/claim/clm_4242495E8AAB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510182697/0001193125-10-182697-index.htm.","url":"https://asof.is/claim/clm_4242495E8AAB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"94,600,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4242495E8AAB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2010, filed 2010-08-09"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 319,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_64C06A49905A, https://asof.is/claim/clm_64C06A49905A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510182697/0001193125-10-182697-index.htm.","url":"https://asof.is/claim/clm_64C06A49905A","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"319,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_64C06A49905A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2010, filed 2010-08-09"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 6,745,500,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_8779E5EE9228, https://asof.is/claim/clm_8779E5EE9228, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510182697/0001193125-10-182697-index.htm.","url":"https://asof.is/claim/clm_8779E5EE9228","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"6,745,500,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8779E5EE9228","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2010, filed 2010-08-09"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 10,060,100,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_AEABF0C0A67C, https://asof.is/claim/clm_AEABF0C0A67C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510182697/0001193125-10-182697-index.htm.","url":"https://asof.is/claim/clm_AEABF0C0A67C","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"10,060,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AEABF0C0A67C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2010, filed 2010-08-09"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 1,758,200,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_CBC34D6436B5, https://asof.is/claim/clm_CBC34D6436B5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510182697/0001193125-10-182697-index.htm.","url":"https://asof.is/claim/clm_CBC34D6436B5","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"1,758,200,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CBC34D6436B5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2010, filed 2010-08-09"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 448,100,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_E015B4F07E32, https://asof.is/claim/clm_E015B4F07E32, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510182697/0001193125-10-182697-index.htm.","url":"https://asof.is/claim/clm_E015B4F07E32","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"448,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E015B4F07E32","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2010, filed 2010-08-09"}},{"date":"2010-07-31","until":"2010-10-31","published":"2010-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 396,940,168 shares\", as of 2010-07-31 (until 2010-10-31). Claim clm_3AF4B0A47D26, https://asof.is/claim/clm_3AF4B0A47D26, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510182697/0001193125-10-182697-index.htm.","url":"https://asof.is/claim/clm_3AF4B0A47D26","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"396,940,168 shares","status":"superseded","assertable":true,"id":"clm_3AF4B0A47D26","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2010, filed 2010-08-09"}},{"date":"2010-09-30","until":"2010-12-31","published":"2010-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 7,306,000,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_3FD431872E64, https://asof.is/claim/clm_3FD431872E64, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510248001/0001193125-10-248001-index.htm.","url":"https://asof.is/claim/clm_3FD431872E64","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"7,306,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3FD431872E64","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2010, filed 2010-11-04"}},{"date":"2010-09-30","until":"2010-12-31","published":"2010-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 925,600,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_84F0F7B15DF7, https://asof.is/claim/clm_84F0F7B15DF7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510248001/0001193125-10-248001-index.htm.","url":"https://asof.is/claim/clm_84F0F7B15DF7","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"925,600,000 United States dollar","status":"superseded","assertable":true,"id":"clm_84F0F7B15DF7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2010, filed 2010-11-04"}},{"date":"2010-09-30","until":"2011-03-31","published":"2010-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 1,767,600,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_B57E59613AD4, https://asof.is/claim/clm_B57E59613AD4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510248001/0001193125-10-248001-index.htm.","url":"https://asof.is/claim/clm_B57E59613AD4","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"1,767,600,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B57E59613AD4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2010, filed 2010-11-04"}},{"date":"2010-09-30","until":"2010-12-31","published":"2010-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 10,771,900,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_BBDF10422E57, https://asof.is/claim/clm_BBDF10422E57, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510248001/0001193125-10-248001-index.htm.","url":"https://asof.is/claim/clm_BBDF10422E57","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"10,771,900,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BBDF10422E57","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2010, filed 2010-11-04"}},{"date":"2010-09-30","until":"2011-03-31","published":"2010-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 337,700,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_DAD4EC978E32, https://asof.is/claim/clm_DAD4EC978E32, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510248001/0001193125-10-248001-index.htm.","url":"https://asof.is/claim/clm_DAD4EC978E32","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"337,700,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DAD4EC978E32","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2010, filed 2010-11-04"}},{"date":"2010-09-30","until":"2011-03-31","published":"2010-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 98,600,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_EAA78D9EE805, https://asof.is/claim/clm_EAA78D9EE805, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510248001/0001193125-10-248001-index.htm.","url":"https://asof.is/claim/clm_EAA78D9EE805","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"98,600,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EAA78D9EE805","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2010, filed 2010-11-04"}},{"date":"2010-09-30","until":"2011-03-31","published":"2010-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 470,500,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_F0F14E4257C6, https://asof.is/claim/clm_F0F14E4257C6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510248001/0001193125-10-248001-index.htm.","url":"https://asof.is/claim/clm_F0F14E4257C6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"470,500,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F0F14E4257C6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2010, filed 2010-11-04"}},{"date":"2010-10-31","until":"2011-01-31","published":"2010-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 397,120,134 shares\", as of 2010-10-31 (until 2011-01-31). Claim clm_FA5DD9597DE6, https://asof.is/claim/clm_FA5DD9597DE6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312510248001/0001193125-10-248001-index.htm.","url":"https://asof.is/claim/clm_FA5DD9597DE6","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"397,120,134 shares","status":"superseded","assertable":true,"id":"clm_FA5DD9597DE6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2010, filed 2010-11-04"}},{"date":"2010-12-31","until":"2011-12-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 393,900,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_09B4BCBF5BDF, https://asof.is/claim/clm_09B4BCBF5BDF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511039845/0001193125-11-039845-index.htm.","url":"https://asof.is/claim/clm_09B4BCBF5BDF","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"393,900,000 United States dollar","status":"superseded","assertable":true,"id":"clm_09B4BCBF5BDF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2011-12-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 1,273,400,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_430593B08B13, https://asof.is/claim/clm_430593B08B13, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511039845/0001193125-11-039845-index.htm.","url":"https://asof.is/claim/clm_430593B08B13","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"1,273,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_430593B08B13","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2011-12-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 1,751,400,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_52183107FA7C, https://asof.is/claim/clm_52183107FA7C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511039845/0001193125-11-039845-index.htm.","url":"https://asof.is/claim/clm_52183107FA7C","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"1,751,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_52183107FA7C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2011-12-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 7,320,000,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_771A4BAC2913, https://asof.is/claim/clm_771A4BAC2913, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511039845/0001193125-11-039845-index.htm.","url":"https://asof.is/claim/clm_771A4BAC2913","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"7,320,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_771A4BAC2913","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2011-03-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 10,895,100,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_96109D869633, https://asof.is/claim/clm_96109D869633, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511039845/0001193125-11-039845-index.htm.","url":"https://asof.is/claim/clm_96109D869633","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"10,895,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_96109D869633","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2011-03-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,757,600,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_C4A50A3BE9AA, https://asof.is/claim/clm_C4A50A3BE9AA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511039845/0001193125-11-039845-index.htm.","url":"https://asof.is/claim/clm_C4A50A3BE9AA","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,757,600,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C4A50A3BE9AA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2011-03-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 7,173,600,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_FACB59F74ED1, https://asof.is/claim/clm_FACB59F74ED1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511039845/0001193125-11-039845-index.htm.","url":"https://asof.is/claim/clm_FACB59F74ED1","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"7,173,600,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FACB59F74ED1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2010, filed 2011-02-18"}},{"date":"2011-01-31","until":"2011-03-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 391,246,163 shares\", as of 2011-01-31 (until 2011-03-31). Claim clm_58A5BD5E17B3, https://asof.is/claim/clm_58A5BD5E17B3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511039845/0001193125-11-039845-index.htm.","url":"https://asof.is/claim/clm_58A5BD5E17B3","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"391,246,163 shares","status":"superseded","assertable":true,"id":"clm_58A5BD5E17B3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2010, filed 2011-02-18"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 735,100,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_0A3347E31839, https://asof.is/claim/clm_0A3347E31839, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511125202/0001193125-11-125202-index.htm.","url":"https://asof.is/claim/clm_0A3347E31839","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"735,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0A3347E31839","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2011, filed 2011-05-04"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 307,400,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_1A9692B88471, https://asof.is/claim/clm_1A9692B88471, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511125202/0001193125-11-125202-index.htm.","url":"https://asof.is/claim/clm_1A9692B88471","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"307,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1A9692B88471","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2011, filed 2011-05-04"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 11,231,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_967835D91E83, https://asof.is/claim/clm_967835D91E83, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511125202/0001193125-11-125202-index.htm.","url":"https://asof.is/claim/clm_967835D91E83","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"11,231,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_967835D91E83","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2011, filed 2011-05-04"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 423,500,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_A6A0829FA05D, https://asof.is/claim/clm_A6A0829FA05D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511125202/0001193125-11-125202-index.htm.","url":"https://asof.is/claim/clm_A6A0829FA05D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"423,500,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A6A0829FA05D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2011, filed 2011-05-04"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 110,900,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_ADE5E43F37CB, https://asof.is/claim/clm_ADE5E43F37CB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511125202/0001193125-11-125202-index.htm.","url":"https://asof.is/claim/clm_ADE5E43F37CB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"110,900,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ADE5E43F37CB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2011, filed 2011-05-04"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 7,452,400,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_EFE9BF5E6495, https://asof.is/claim/clm_EFE9BF5E6495, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511125202/0001193125-11-125202-index.htm.","url":"https://asof.is/claim/clm_EFE9BF5E6495","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"7,452,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EFE9BF5E6495","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2011, filed 2011-05-04"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,015,200,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_F35D40DE987D, https://asof.is/claim/clm_F35D40DE987D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511125202/0001193125-11-125202-index.htm.","url":"https://asof.is/claim/clm_F35D40DE987D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,015,200,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F35D40DE987D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2011, filed 2011-05-04"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 388,004,426 shares\", as of 2011-03-31 (until 2011-06-30). Claim clm_F3B8ACB36B23, https://asof.is/claim/clm_F3B8ACB36B23, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511125202/0001193125-11-125202-index.htm.","url":"https://asof.is/claim/clm_F3B8ACB36B23","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"388,004,426 shares","status":"superseded","assertable":true,"id":"clm_F3B8ACB36B23","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2011, filed 2011-05-04"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 114,500,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_3A176BA31294, https://asof.is/claim/clm_3A176BA31294, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511200017/0001193125-11-200017-index.htm.","url":"https://asof.is/claim/clm_3A176BA31294","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"114,500,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3A176BA31294","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2011, filed 2011-07-28"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 7,778,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_3B3BD03A0714, https://asof.is/claim/clm_3B3BD03A0714, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511200017/0001193125-11-200017-index.htm.","url":"https://asof.is/claim/clm_3B3BD03A0714","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"7,778,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3B3BD03A0714","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2011, filed 2011-07-28"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 400,300,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_5951A87F24E4, https://asof.is/claim/clm_5951A87F24E4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511200017/0001193125-11-200017-index.htm.","url":"https://asof.is/claim/clm_5951A87F24E4","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"400,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5951A87F24E4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2011, filed 2011-07-28"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 497,100,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_682EB9E214DD, https://asof.is/claim/clm_682EB9E214DD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511200017/0001193125-11-200017-index.htm.","url":"https://asof.is/claim/clm_682EB9E214DD","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"497,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_682EB9E214DD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2011, filed 2011-07-28"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 388,328,148 shares\", as of 2011-06-30 (until 2011-09-30). Claim clm_6E2BB278FB92, https://asof.is/claim/clm_6E2BB278FB92, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511200017/0001193125-11-200017-index.htm.","url":"https://asof.is/claim/clm_6E2BB278FB92","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"388,328,148 shares","status":"superseded","assertable":true,"id":"clm_6E2BB278FB92","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2011, filed 2011-07-28"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,045,500,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_70E696D75E5B, https://asof.is/claim/clm_70E696D75E5B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511200017/0001193125-11-200017-index.htm.","url":"https://asof.is/claim/clm_70E696D75E5B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,045,500,000 United States dollar","status":"superseded","assertable":true,"id":"clm_70E696D75E5B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2011, filed 2011-07-28"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 11,596,400,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_A57C916DC66A, https://asof.is/claim/clm_A57C916DC66A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511200017/0001193125-11-200017-index.htm.","url":"https://asof.is/claim/clm_A57C916DC66A","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"11,596,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A57C916DC66A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2011, filed 2011-07-28"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 309,100,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_F67DD8E69C57, https://asof.is/claim/clm_F67DD8E69C57, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312511200017/0001193125-11-200017-index.htm.","url":"https://asof.is/claim/clm_F67DD8E69C57","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"309,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F67DD8E69C57","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2011, filed 2011-07-28"}},{"date":"2011-09-30","until":"2011-12-31","published":"2011-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 810,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_36CC0FF01190, https://asof.is/claim/clm_36CC0FF01190, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076411000151/0000310764-11-000151-index.htm.","url":"https://asof.is/claim/clm_36CC0FF01190","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"810,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_36CC0FF01190","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2011, filed 2011-10-28"}},{"date":"2011-09-30","until":"2011-12-31","published":"2011-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 12,083,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_60F51ED74246, https://asof.is/claim/clm_60F51ED74246, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076411000151/0000310764-11-000151-index.htm.","url":"https://asof.is/claim/clm_60F51ED74246","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"12,083,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_60F51ED74246","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2011, filed 2011-10-28"}},{"date":"2011-09-30","until":"2012-03-31","published":"2011-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,031,000,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_7BF3100E680A, https://asof.is/claim/clm_7BF3100E680A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076411000151/0000310764-11-000151-index.htm.","url":"https://asof.is/claim/clm_7BF3100E680A","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,031,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7BF3100E680A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2011, filed 2011-10-28"}},{"date":"2011-09-30","until":"2012-03-31","published":"2011-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 327,000,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_B8875971D994, https://asof.is/claim/clm_B8875971D994, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076411000151/0000310764-11-000151-index.htm.","url":"https://asof.is/claim/clm_B8875971D994","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"327,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B8875971D994","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2011, filed 2011-10-28"}},{"date":"2011-09-30","until":"2012-03-31","published":"2011-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 444,000,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_BD5A13494A0C, https://asof.is/claim/clm_BD5A13494A0C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076411000151/0000310764-11-000151-index.htm.","url":"https://asof.is/claim/clm_BD5A13494A0C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"444,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BD5A13494A0C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2011, filed 2011-10-28"}},{"date":"2011-09-30","until":"2011-12-31","published":"2011-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 7,557,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_E62840B73F10, https://asof.is/claim/clm_E62840B73F10, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076411000151/0000310764-11-000151-index.htm.","url":"https://asof.is/claim/clm_E62840B73F10","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"7,557,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E62840B73F10","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2011, filed 2011-10-28"}},{"date":"2011-09-30","until":"2012-01-31","published":"2011-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 382,672,989 shares\", as of 2011-09-30 (until 2012-01-31). Claim clm_F3B0E2E24AC7, https://asof.is/claim/clm_F3B0E2E24AC7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076411000151/0000310764-11-000151-index.htm.","url":"https://asof.is/claim/clm_F3B0E2E24AC7","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"382,672,989 shares","status":"superseded","assertable":true,"id":"clm_F3B0E2E24AC7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2011, filed 2011-10-28"}},{"date":"2011-09-30","until":"2012-03-31","published":"2011-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 122,000,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_FA99649C9BF5, https://asof.is/claim/clm_FA99649C9BF5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076411000151/0000310764-11-000151-index.htm.","url":"https://asof.is/claim/clm_FA99649C9BF5","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"122,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FA99649C9BF5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2011, filed 2011-10-28"}},{"date":"2011-12-31","until":"2012-03-31","published":"2012-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 7,683,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_0A8110B489E2, https://asof.is/claim/clm_0A8110B489E2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000031/0000310764-12-000031-index.htm.","url":"https://asof.is/claim/clm_0A8110B489E2","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"7,683,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0A8110B489E2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2011, filed 2012-02-13"}},{"date":"2011-12-31","until":"2012-03-31","published":"2012-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 12,405,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_5E780776CA8E, https://asof.is/claim/clm_5E780776CA8E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000031/0000310764-12-000031-index.htm.","url":"https://asof.is/claim/clm_5E780776CA8E","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"12,405,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5E780776CA8E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2011, filed 2012-02-13"}},{"date":"2011-12-31","until":"2012-12-31","published":"2012-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 8,307,000,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_714A512C3517, https://asof.is/claim/clm_714A512C3517, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000031/0000310764-12-000031-index.htm.","url":"https://asof.is/claim/clm_714A512C3517","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"8,307,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_714A512C3517","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2011, filed 2012-02-13"}},{"date":"2011-12-31","until":"2012-12-31","published":"2012-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 1,686,000,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_74CADB71F483, https://asof.is/claim/clm_74CADB71F483, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000031/0000310764-12-000031-index.htm.","url":"https://asof.is/claim/clm_74CADB71F483","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"1,686,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_74CADB71F483","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2011, filed 2012-02-13"}},{"date":"2011-12-31","until":"2012-12-31","published":"2012-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 1,345,000,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_879B591A6BB5, https://asof.is/claim/clm_879B591A6BB5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000031/0000310764-12-000031-index.htm.","url":"https://asof.is/claim/clm_879B591A6BB5","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"1,345,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_879B591A6BB5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2011, filed 2012-02-13"}},{"date":"2011-12-31","until":"2012-12-31","published":"2012-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 462,000,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_8F1E9988ED59, https://asof.is/claim/clm_8F1E9988ED59, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000031/0000310764-12-000031-index.htm.","url":"https://asof.is/claim/clm_8F1E9988ED59","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"462,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8F1E9988ED59","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2011, filed 2012-02-13"}},{"date":"2011-12-31","until":"2012-03-31","published":"2012-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 905,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_D08481E691E3, https://asof.is/claim/clm_D08481E691E3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000031/0000310764-12-000031-index.htm.","url":"https://asof.is/claim/clm_D08481E691E3","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"905,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D08481E691E3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2011, filed 2012-02-13"}},{"date":"2012-01-31","until":"2012-03-31","published":"2012-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 381,020,053 shares\", as of 2012-01-31 (until 2012-03-31). Claim clm_3ECBF016602B, https://asof.is/claim/clm_3ECBF016602B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000031/0000310764-12-000031-index.htm.","url":"https://asof.is/claim/clm_3ECBF016602B","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"381,020,053 shares","status":"superseded","assertable":true,"id":"clm_3ECBF016602B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2011, filed 2012-02-13"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 380,933,033 shares\", as of 2012-03-31 (until 2012-06-30). Claim clm_0439467E001A, https://asof.is/claim/clm_0439467E001A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000129/0000310764-12-000129-index.htm.","url":"https://asof.is/claim/clm_0439467E001A","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"380,933,033 shares","status":"superseded","assertable":true,"id":"clm_0439467E001A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2012, filed 2012-04-24"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 8,022,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_04BB91B99CBE, https://asof.is/claim/clm_04BB91B99CBE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000129/0000310764-12-000129-index.htm.","url":"https://asof.is/claim/clm_04BB91B99CBE","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"8,022,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_04BB91B99CBE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2012, filed 2012-04-24"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,161,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_28521A6633DC, https://asof.is/claim/clm_28521A6633DC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000129/0000310764-12-000129-index.htm.","url":"https://asof.is/claim/clm_28521A6633DC","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,161,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_28521A6633DC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2012, filed 2012-04-24"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 12,459,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_395EAF6CEA9A, https://asof.is/claim/clm_395EAF6CEA9A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000129/0000310764-12-000129-index.htm.","url":"https://asof.is/claim/clm_395EAF6CEA9A","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"12,459,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_395EAF6CEA9A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2012, filed 2012-04-24"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 350,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_5F4FAEB970E7, https://asof.is/claim/clm_5F4FAEB970E7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000129/0000310764-12-000129-index.htm.","url":"https://asof.is/claim/clm_5F4FAEB970E7","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"350,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5F4FAEB970E7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2012, filed 2012-04-24"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 690,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_831B20C0389A, https://asof.is/claim/clm_831B20C0389A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000129/0000310764-12-000129-index.htm.","url":"https://asof.is/claim/clm_831B20C0389A","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"690,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_831B20C0389A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2012, filed 2012-04-24"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 476,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_97FB6B006D98, https://asof.is/claim/clm_97FB6B006D98, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000129/0000310764-12-000129-index.htm.","url":"https://asof.is/claim/clm_97FB6B006D98","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"476,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_97FB6B006D98","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2012, filed 2012-04-24"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 112,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_F327EBF7C231, https://asof.is/claim/clm_F327EBF7C231, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000129/0000310764-12-000129-index.htm.","url":"https://asof.is/claim/clm_F327EBF7C231","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"112,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F327EBF7C231","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2012, filed 2012-04-24"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 325,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_32DC13323231, https://asof.is/claim/clm_32DC13323231, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000178/0000310764-12-000178-index.htm.","url":"https://asof.is/claim/clm_32DC13323231","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"325,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_32DC13323231","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2012, filed 2012-07-24"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 12,262,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_46C754610144, https://asof.is/claim/clm_46C754610144, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000178/0000310764-12-000178-index.htm.","url":"https://asof.is/claim/clm_46C754610144","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"12,262,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_46C754610144","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2012, filed 2012-07-24"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 116,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_49EFD328D4FB, https://asof.is/claim/clm_49EFD328D4FB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000178/0000310764-12-000178-index.htm.","url":"https://asof.is/claim/clm_49EFD328D4FB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"116,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_49EFD328D4FB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2012, filed 2012-07-24"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 445,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_654DA8C72539, https://asof.is/claim/clm_654DA8C72539, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000178/0000310764-12-000178-index.htm.","url":"https://asof.is/claim/clm_654DA8C72539","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"445,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_654DA8C72539","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2012, filed 2012-07-24"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,106,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_6E493FD75232, https://asof.is/claim/clm_6E493FD75232, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000178/0000310764-12-000178-index.htm.","url":"https://asof.is/claim/clm_6E493FD75232","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,106,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6E493FD75232","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2012, filed 2012-07-24"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 380,444,166 shares\", as of 2012-06-30 (until 2012-09-30). Claim clm_9F4F92C48449, https://asof.is/claim/clm_9F4F92C48449, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000178/0000310764-12-000178-index.htm.","url":"https://asof.is/claim/clm_9F4F92C48449","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"380,444,166 shares","status":"superseded","assertable":true,"id":"clm_9F4F92C48449","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2012, filed 2012-07-24"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,393,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_B24FCC5CA797, https://asof.is/claim/clm_B24FCC5CA797, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000178/0000310764-12-000178-index.htm.","url":"https://asof.is/claim/clm_B24FCC5CA797","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,393,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B24FCC5CA797","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2012, filed 2012-07-24"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 7,952,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_FEFEA1C75886, https://asof.is/claim/clm_FEFEA1C75886, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000178/0000310764-12-000178-index.htm.","url":"https://asof.is/claim/clm_FEFEA1C75886","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"7,952,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FEFEA1C75886","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2012, filed 2012-07-24"}},{"date":"2012-09-30","until":"2012-12-31","published":"2012-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,423,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_016C59371F56, https://asof.is/claim/clm_016C59371F56, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000240/0000310764-12-000240-index.htm.","url":"https://asof.is/claim/clm_016C59371F56","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,423,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_016C59371F56","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2012, filed 2012-10-22"}},{"date":"2012-09-30","until":"2013-03-31","published":"2012-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,052,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_373662D6C03E, https://asof.is/claim/clm_373662D6C03E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000240/0000310764-12-000240-index.htm.","url":"https://asof.is/claim/clm_373662D6C03E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,052,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_373662D6C03E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2012, filed 2012-10-22"}},{"date":"2012-09-30","until":"2012-12-31","published":"2012-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 12,777,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_3DF6FF4559C7, https://asof.is/claim/clm_3DF6FF4559C7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000240/0000310764-12-000240-index.htm.","url":"https://asof.is/claim/clm_3DF6FF4559C7","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"12,777,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3DF6FF4559C7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2012, filed 2012-10-22"}},{"date":"2012-09-30","until":"2013-03-31","published":"2012-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 450,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_3E7FA3DA7383, https://asof.is/claim/clm_3E7FA3DA7383, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000240/0000310764-12-000240-index.htm.","url":"https://asof.is/claim/clm_3E7FA3DA7383","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"450,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3E7FA3DA7383","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2012, filed 2012-10-22"}},{"date":"2012-09-30","until":"2013-03-31","published":"2012-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 353,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_4999CDFED899, https://asof.is/claim/clm_4999CDFED899, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000240/0000310764-12-000240-index.htm.","url":"https://asof.is/claim/clm_4999CDFED899","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"353,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4999CDFED899","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2012, filed 2012-10-22"}},{"date":"2012-09-30","until":"2013-01-31","published":"2012-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 380,200,593 shares\", as of 2012-09-30 (until 2013-01-31). Claim clm_98831619F4EE, https://asof.is/claim/clm_98831619F4EE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000240/0000310764-12-000240-index.htm.","url":"https://asof.is/claim/clm_98831619F4EE","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"380,200,593 shares","status":"superseded","assertable":true,"id":"clm_98831619F4EE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2012, filed 2012-10-22"}},{"date":"2012-09-30","until":"2012-12-31","published":"2012-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 8,361,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_B393BDC97C4C, https://asof.is/claim/clm_B393BDC97C4C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000240/0000310764-12-000240-index.htm.","url":"https://asof.is/claim/clm_B393BDC97C4C","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"8,361,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B393BDC97C4C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2012, filed 2012-10-22"}},{"date":"2012-09-30","until":"2013-03-31","published":"2012-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 114,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_D5B6EF211FA1, https://asof.is/claim/clm_D5B6EF211FA1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076412000240/0000310764-12-000240-index.htm.","url":"https://asof.is/claim/clm_D5B6EF211FA1","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"114,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D5B6EF211FA1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2012, filed 2012-10-22"}},{"date":"2012-12-31","until":"2013-03-31","published":"2013-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 8,597,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_3061458A89D7, https://asof.is/claim/clm_3061458A89D7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000054/0000310764-13-000054-index.htm.","url":"https://asof.is/claim/clm_3061458A89D7","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"8,597,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3061458A89D7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2012, filed 2013-02-27"}},{"date":"2012-12-31","until":"2013-12-31","published":"2013-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 8,657,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_374CE38BDCDA, https://asof.is/claim/clm_374CE38BDCDA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000054/0000310764-13-000054-index.htm.","url":"https://asof.is/claim/clm_374CE38BDCDA","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"8,657,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_374CE38BDCDA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2012, filed 2013-02-27"}},{"date":"2012-12-31","until":"2013-12-31","published":"2013-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 471,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_4467B6A8185C, https://asof.is/claim/clm_4467B6A8185C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000054/0000310764-13-000054-index.htm.","url":"https://asof.is/claim/clm_4467B6A8185C","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"471,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4467B6A8185C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2012, filed 2013-02-27"}},{"date":"2012-12-31","until":"2013-03-31","published":"2013-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 13,206,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_931E974CEAA8, https://asof.is/claim/clm_931E974CEAA8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000054/0000310764-13-000054-index.htm.","url":"https://asof.is/claim/clm_931E974CEAA8","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"13,206,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_931E974CEAA8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2012, filed 2013-02-27"}},{"date":"2012-12-31","until":"2013-12-31","published":"2013-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 1,298,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_A9E62A4E7C2C, https://asof.is/claim/clm_A9E62A4E7C2C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000054/0000310764-13-000054-index.htm.","url":"https://asof.is/claim/clm_A9E62A4E7C2C","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"1,298,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A9E62A4E7C2C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2012, filed 2013-02-27"}},{"date":"2012-12-31","until":"2013-12-31","published":"2013-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 1,741,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_B2E688395FA4, https://asof.is/claim/clm_B2E688395FA4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000054/0000310764-13-000054-index.htm.","url":"https://asof.is/claim/clm_B2E688395FA4","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"1,741,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B2E688395FA4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2012, filed 2013-02-27"}},{"date":"2012-12-31","until":"2013-03-31","published":"2013-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,395,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_FF30A5FB9645, https://asof.is/claim/clm_FF30A5FB9645, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000054/0000310764-13-000054-index.htm.","url":"https://asof.is/claim/clm_FF30A5FB9645","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,395,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FF30A5FB9645","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2012, filed 2013-02-27"}},{"date":"2013-01-31","until":"2013-03-31","published":"2013-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 380,512,172 shares\", as of 2013-01-31 (until 2013-03-31). Claim clm_EFA405775A90, https://asof.is/claim/clm_EFA405775A90, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000054/0000310764-13-000054-index.htm.","url":"https://asof.is/claim/clm_EFA405775A90","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"380,512,172 shares","status":"superseded","assertable":true,"id":"clm_EFA405775A90","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2012, filed 2013-02-27"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 386,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_10E321D9598C, https://asof.is/claim/clm_10E321D9598C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000110/0000310764-13-000110-index.htm.","url":"https://asof.is/claim/clm_10E321D9598C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"386,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_10E321D9598C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2013, filed 2013-04-30"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,913,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_1AC19489738E, https://asof.is/claim/clm_1AC19489738E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000110/0000310764-13-000110-index.htm.","url":"https://asof.is/claim/clm_1AC19489738E","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,913,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1AC19489738E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2013, filed 2013-04-30"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 378,056,811 shares\", as of 2013-03-31 (until 2013-06-30). Claim clm_2436FFED5F71, https://asof.is/claim/clm_2436FFED5F71, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000110/0000310764-13-000110-index.htm.","url":"https://asof.is/claim/clm_2436FFED5F71","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"378,056,811 shares","status":"superseded","assertable":true,"id":"clm_2436FFED5F71","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2013, filed 2013-04-30"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 129,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_4BFC9C378319, https://asof.is/claim/clm_4BFC9C378319, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000110/0000310764-13-000110-index.htm.","url":"https://asof.is/claim/clm_4BFC9C378319","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"129,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4BFC9C378319","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2013, filed 2013-04-30"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,190,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_57431BE95E2D, https://asof.is/claim/clm_57431BE95E2D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000110/0000310764-13-000110-index.htm.","url":"https://asof.is/claim/clm_57431BE95E2D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,190,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_57431BE95E2D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2013, filed 2013-04-30"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 14,089,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_70BBF48F0D04, https://asof.is/claim/clm_70BBF48F0D04, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000110/0000310764-13-000110-index.htm.","url":"https://asof.is/claim/clm_70BBF48F0D04","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"14,089,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_70BBF48F0D04","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2013, filed 2013-04-30"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 8,456,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_8761E9B8A37D, https://asof.is/claim/clm_8761E9B8A37D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000110/0000310764-13-000110-index.htm.","url":"https://asof.is/claim/clm_8761E9B8A37D","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"8,456,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8761E9B8A37D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2013, filed 2013-04-30"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 304,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_9F7D87082672, https://asof.is/claim/clm_9F7D87082672, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000110/0000310764-13-000110-index.htm.","url":"https://asof.is/claim/clm_9F7D87082672","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"304,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9F7D87082672","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2013, filed 2013-04-30"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 290,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_013FCF89EAEE, https://asof.is/claim/clm_013FCF89EAEE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000158/0000310764-13-000158-index.htm.","url":"https://asof.is/claim/clm_013FCF89EAEE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"290,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_013FCF89EAEE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2013, filed 2013-07-23"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 8,603,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_0A6A6FB04522, https://asof.is/claim/clm_0A6A6FB04522, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000158/0000310764-13-000158-index.htm.","url":"https://asof.is/claim/clm_0A6A6FB04522","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"8,603,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0A6A6FB04522","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2013, filed 2013-07-23"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 132,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_2919511E9B5F, https://asof.is/claim/clm_2919511E9B5F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000158/0000310764-13-000158-index.htm.","url":"https://asof.is/claim/clm_2919511E9B5F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"132,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2919511E9B5F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2013, filed 2013-07-23"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,212,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_6B6F1202F4D9, https://asof.is/claim/clm_6B6F1202F4D9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000158/0000310764-13-000158-index.htm.","url":"https://asof.is/claim/clm_6B6F1202F4D9","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,212,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6B6F1202F4D9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2013, filed 2013-07-23"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 971,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_BA4F42CE6FEC, https://asof.is/claim/clm_BA4F42CE6FEC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000158/0000310764-13-000158-index.htm.","url":"https://asof.is/claim/clm_BA4F42CE6FEC","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"971,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BA4F42CE6FEC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2013, filed 2013-07-23"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 213,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_C93D425C0802, https://asof.is/claim/clm_C93D425C0802, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000158/0000310764-13-000158-index.htm.","url":"https://asof.is/claim/clm_C93D425C0802","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"213,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C93D425C0802","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2013, filed 2013-07-23"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 378,132,187 shares\", as of 2013-06-30 (until 2013-09-30). Claim clm_DBF425D6DEB1, https://asof.is/claim/clm_DBF425D6DEB1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000158/0000310764-13-000158-index.htm.","url":"https://asof.is/claim/clm_DBF425D6DEB1","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"378,132,187 shares","status":"superseded","assertable":true,"id":"clm_DBF425D6DEB1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2013, filed 2013-07-23"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 14,382,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_E9B2E55F410C, https://asof.is/claim/clm_E9B2E55F410C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000158/0000310764-13-000158-index.htm.","url":"https://asof.is/claim/clm_E9B2E55F410C","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"14,382,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E9B2E55F410C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2013, filed 2013-07-23"}},{"date":"2013-09-30","until":"2013-12-31","published":"2013-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,110,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_2654F5071578, https://asof.is/claim/clm_2654F5071578, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000210/0000310764-13-000210-index.htm.","url":"https://asof.is/claim/clm_2654F5071578","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,110,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2654F5071578","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2013, filed 2013-10-23"}},{"date":"2013-09-30","until":"2014-03-31","published":"2013-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 103,000,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_4B18581C9B70, https://asof.is/claim/clm_4B18581C9B70, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000210/0000310764-13-000210-index.htm.","url":"https://asof.is/claim/clm_4B18581C9B70","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"103,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4B18581C9B70","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2013, filed 2013-10-23"}},{"date":"2013-09-30","until":"2014-01-31","published":"2013-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 378,418,945 shares\", as of 2013-09-30 (until 2014-01-31). Claim clm_4E7BF3E65865, https://asof.is/claim/clm_4E7BF3E65865, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000210/0000310764-13-000210-index.htm.","url":"https://asof.is/claim/clm_4E7BF3E65865","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"378,418,945 shares","status":"superseded","assertable":true,"id":"clm_4E7BF3E65865","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2013, filed 2013-10-23"}},{"date":"2013-09-30","until":"2013-12-31","published":"2013-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 8,737,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_52D4B9A2F2FF, https://asof.is/claim/clm_52D4B9A2F2FF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000210/0000310764-13-000210-index.htm.","url":"https://asof.is/claim/clm_52D4B9A2F2FF","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"8,737,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_52D4B9A2F2FF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2013, filed 2013-10-23"}},{"date":"2013-09-30","until":"2014-03-31","published":"2013-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 136,000,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_63E0B610D53F, https://asof.is/claim/clm_63E0B610D53F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000210/0000310764-13-000210-index.htm.","url":"https://asof.is/claim/clm_63E0B610D53F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"136,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_63E0B610D53F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2013, filed 2013-10-23"}},{"date":"2013-09-30","until":"2013-12-31","published":"2013-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 14,883,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_64FDF922921A, https://asof.is/claim/clm_64FDF922921A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000210/0000310764-13-000210-index.htm.","url":"https://asof.is/claim/clm_64FDF922921A","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"14,883,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_64FDF922921A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2013, filed 2013-10-23"}},{"date":"2013-09-30","until":"2014-03-31","published":"2013-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 150,000,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_77255FEAEA2C, https://asof.is/claim/clm_77255FEAEA2C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000210/0000310764-13-000210-index.htm.","url":"https://asof.is/claim/clm_77255FEAEA2C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"150,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_77255FEAEA2C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2013, filed 2013-10-23"}},{"date":"2013-09-30","until":"2014-03-31","published":"2013-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,151,000,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_80B3B207ABF2, https://asof.is/claim/clm_80B3B207ABF2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076413000210/0000310764-13-000210-index.htm.","url":"https://asof.is/claim/clm_80B3B207ABF2","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,151,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_80B3B207ABF2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2013, filed 2013-10-23"}},{"date":"2013-12-31","until":"2014-12-31","published":"2014-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 1,006,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_1D5DEC2D7593, https://asof.is/claim/clm_1D5DEC2D7593, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000021/0000310764-14-000021-index.htm.","url":"https://asof.is/claim/clm_1D5DEC2D7593","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"1,006,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1D5DEC2D7593","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2013, filed 2014-02-13"}},{"date":"2013-12-31","until":"2014-12-31","published":"2014-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 536,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_39946B205064, https://asof.is/claim/clm_39946B205064, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000021/0000310764-14-000021-index.htm.","url":"https://asof.is/claim/clm_39946B205064","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"536,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_39946B205064","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2013, filed 2014-02-13"}},{"date":"2013-12-31","until":"2014-03-31","published":"2014-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 9,047,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_6D594018C9EB, https://asof.is/claim/clm_6D594018C9EB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000021/0000310764-14-000021-index.htm.","url":"https://asof.is/claim/clm_6D594018C9EB","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"9,047,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6D594018C9EB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2013, filed 2014-02-13"}},{"date":"2013-12-31","until":"2014-12-31","published":"2014-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 1,256,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_9A2884161643, https://asof.is/claim/clm_9A2884161643, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000021/0000310764-14-000021-index.htm.","url":"https://asof.is/claim/clm_9A2884161643","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"1,256,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9A2884161643","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2013, filed 2014-02-13"}},{"date":"2013-12-31","until":"2014-03-31","published":"2014-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,339,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_9C31AEC61C38, https://asof.is/claim/clm_9C31AEC61C38, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000021/0000310764-14-000021-index.htm.","url":"https://asof.is/claim/clm_9C31AEC61C38","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,339,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9C31AEC61C38","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2013, filed 2014-02-13"}},{"date":"2013-12-31","until":"2014-03-31","published":"2014-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 15,743,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_CDFFEAD60560, https://asof.is/claim/clm_CDFFEAD60560, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000021/0000310764-14-000021-index.htm.","url":"https://asof.is/claim/clm_CDFFEAD60560","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"15,743,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CDFFEAD60560","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2013, filed 2014-02-13"}},{"date":"2013-12-31","until":"2014-12-31","published":"2014-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 9,021,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_F46DC701B5F0, https://asof.is/claim/clm_F46DC701B5F0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000021/0000310764-14-000021-index.htm.","url":"https://asof.is/claim/clm_F46DC701B5F0","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"9,021,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F46DC701B5F0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2013, filed 2014-02-13"}},{"date":"2014-01-31","until":"2014-03-31","published":"2014-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 377,870,936 shares\", as of 2014-01-31 (until 2014-03-31). Claim clm_422DD1E8A85E, https://asof.is/claim/clm_422DD1E8A85E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000021/0000310764-14-000021-index.htm.","url":"https://asof.is/claim/clm_422DD1E8A85E","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"377,870,936 shares","status":"superseded","assertable":true,"id":"clm_422DD1E8A85E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2013, filed 2014-02-13"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,305,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_2B0A94066848, https://asof.is/claim/clm_2B0A94066848, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000091/0000310764-14-000091-index.htm.","url":"https://asof.is/claim/clm_2B0A94066848","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,305,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2B0A94066848","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2014, filed 2014-04-24"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 16,159,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_5D5C4746CF27, https://asof.is/claim/clm_5D5C4746CF27, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000091/0000310764-14-000091-index.htm.","url":"https://asof.is/claim/clm_5D5C4746CF27","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"16,159,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5D5C4746CF27","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2014, filed 2014-04-24"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 379,093,934 shares\", as of 2014-03-31 (until 2014-06-30). Claim clm_610015486BC4, https://asof.is/claim/clm_610015486BC4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000091/0000310764-14-000091-index.htm.","url":"https://asof.is/claim/clm_610015486BC4","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"379,093,934 shares","status":"superseded","assertable":true,"id":"clm_610015486BC4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2014, filed 2014-04-24"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 9,063,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_62D65678F1E5, https://asof.is/claim/clm_62D65678F1E5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000091/0000310764-14-000091-index.htm.","url":"https://asof.is/claim/clm_62D65678F1E5","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"9,063,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_62D65678F1E5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2014, filed 2014-04-24"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 150,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_ACABC04C52F6, https://asof.is/claim/clm_ACABC04C52F6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000091/0000310764-14-000091-index.htm.","url":"https://asof.is/claim/clm_ACABC04C52F6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"150,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ACABC04C52F6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2014, filed 2014-04-24"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 70,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_B025D18AE8DA, https://asof.is/claim/clm_B025D18AE8DA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000091/0000310764-14-000091-index.htm.","url":"https://asof.is/claim/clm_B025D18AE8DA","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"70,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B025D18AE8DA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2014, filed 2014-04-24"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 131,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_B54E5928AFD2, https://asof.is/claim/clm_B54E5928AFD2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000091/0000310764-14-000091-index.htm.","url":"https://asof.is/claim/clm_B54E5928AFD2","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"131,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B54E5928AFD2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2014, filed 2014-04-24"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,381,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_C1DF025982E9, https://asof.is/claim/clm_C1DF025982E9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000091/0000310764-14-000091-index.htm.","url":"https://asof.is/claim/clm_C1DF025982E9","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,381,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C1DF025982E9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2014, filed 2014-04-24"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 128,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_000897C65CD1, https://asof.is/claim/clm_000897C65CD1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000137/0000310764-14-000137-index.htm.","url":"https://asof.is/claim/clm_000897C65CD1","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"128,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_000897C65CD1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2014, filed 2014-07-24"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,319,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_381AF081AEF4, https://asof.is/claim/clm_381AF081AEF4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000137/0000310764-14-000137-index.htm.","url":"https://asof.is/claim/clm_381AF081AEF4","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,319,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_381AF081AEF4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2014, filed 2014-07-24"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 17,229,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_68D719844FD4, https://asof.is/claim/clm_68D719844FD4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000137/0000310764-14-000137-index.htm.","url":"https://asof.is/claim/clm_68D719844FD4","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"17,229,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_68D719844FD4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2014, filed 2014-07-24"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 9,002,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_A5E40A424572, https://asof.is/claim/clm_A5E40A424572, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000137/0000310764-14-000137-index.htm.","url":"https://asof.is/claim/clm_A5E40A424572","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"9,002,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A5E40A424572","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2014, filed 2014-07-24"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 197,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_A6067C5557FE, https://asof.is/claim/clm_A6067C5557FE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000137/0000310764-14-000137-index.htm.","url":"https://asof.is/claim/clm_A6067C5557FE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"197,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A6067C5557FE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2014, filed 2014-07-24"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,363,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_D3216AB26C45, https://asof.is/claim/clm_D3216AB26C45, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000137/0000310764-14-000137-index.htm.","url":"https://asof.is/claim/clm_D3216AB26C45","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,363,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D3216AB26C45","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2014, filed 2014-07-24"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 378,582,992 shares\", as of 2014-06-30 (until 2014-09-30). Claim clm_F8CB558773CC, https://asof.is/claim/clm_F8CB558773CC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000137/0000310764-14-000137-index.htm.","url":"https://asof.is/claim/clm_F8CB558773CC","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"378,582,992 shares","status":"superseded","assertable":true,"id":"clm_F8CB558773CC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2014, filed 2014-07-24"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 158,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_FE5AAE871498, https://asof.is/claim/clm_FE5AAE871498, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000137/0000310764-14-000137-index.htm.","url":"https://asof.is/claim/clm_FE5AAE871498","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"158,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FE5AAE871498","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2014, filed 2014-07-24"}},{"date":"2014-09-30","until":"2015-01-31","published":"2014-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 378,320,513 shares\", as of 2014-09-30 (until 2015-01-31). Claim clm_0DA235638A1E, https://asof.is/claim/clm_0DA235638A1E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000187/0000310764-14-000187-index.htm.","url":"https://asof.is/claim/clm_0DA235638A1E","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"378,320,513 shares","status":"superseded","assertable":true,"id":"clm_0DA235638A1E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2014, filed 2014-10-23"}},{"date":"2014-09-30","until":"2015-03-31","published":"2014-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 153,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_0E6450F66A56, https://asof.is/claim/clm_0E6450F66A56, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000187/0000310764-14-000187-index.htm.","url":"https://asof.is/claim/clm_0E6450F66A56","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"153,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0E6450F66A56","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2014, filed 2014-10-23"}},{"date":"2014-09-30","until":"2015-03-31","published":"2014-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 57,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_198E88F06555, https://asof.is/claim/clm_198E88F06555, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000187/0000310764-14-000187-index.htm.","url":"https://asof.is/claim/clm_198E88F06555","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"57,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_198E88F06555","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2014, filed 2014-10-23"}},{"date":"2014-09-30","until":"2014-12-31","published":"2014-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 17,515,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_44E88EDF2E6B, https://asof.is/claim/clm_44E88EDF2E6B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000187/0000310764-14-000187-index.htm.","url":"https://asof.is/claim/clm_44E88EDF2E6B","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"17,515,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_44E88EDF2E6B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2014, filed 2014-10-23"}},{"date":"2014-09-30","until":"2015-03-31","published":"2014-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,389,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_56EDE77D2F7D, https://asof.is/claim/clm_56EDE77D2F7D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000187/0000310764-14-000187-index.htm.","url":"https://asof.is/claim/clm_56EDE77D2F7D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,389,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_56EDE77D2F7D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2014, filed 2014-10-23"}},{"date":"2014-09-30","until":"2014-12-31","published":"2014-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 8,624,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_86208FBC7B21, https://asof.is/claim/clm_86208FBC7B21, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000187/0000310764-14-000187-index.htm.","url":"https://asof.is/claim/clm_86208FBC7B21","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"8,624,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_86208FBC7B21","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2014, filed 2014-10-23"}},{"date":"2014-09-30","until":"2014-12-31","published":"2014-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,356,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_BBF774311AE2, https://asof.is/claim/clm_BBF774311AE2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000187/0000310764-14-000187-index.htm.","url":"https://asof.is/claim/clm_BBF774311AE2","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,356,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BBF774311AE2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2014, filed 2014-10-23"}},{"date":"2014-09-30","until":"2015-03-31","published":"2014-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 450,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_ECA984DFDF21, https://asof.is/claim/clm_ECA984DFDF21, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076414000187/0000310764-14-000187-index.htm.","url":"https://asof.is/claim/clm_ECA984DFDF21","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"450,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ECA984DFDF21","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2014, filed 2014-10-23"}},{"date":"2014-12-31","until":"2015-03-31","published":"2015-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,795,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_07B4C3BAA73E, https://asof.is/claim/clm_07B4C3BAA73E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000022/0000310764-15-000022-index.htm.","url":"https://asof.is/claim/clm_07B4C3BAA73E","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,795,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_07B4C3BAA73E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2014, filed 2015-02-12"}},{"date":"2014-12-31","until":"2015-03-31","published":"2015-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 8,595,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_09A9AE8E0E0C, https://asof.is/claim/clm_09A9AE8E0E0C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000022/0000310764-15-000022-index.htm.","url":"https://asof.is/claim/clm_09A9AE8E0E0C","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"8,595,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_09A9AE8E0E0C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2014, filed 2015-02-12"}},{"date":"2014-12-31","until":"2015-12-31","published":"2015-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 614,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_201FD7A30A4D, https://asof.is/claim/clm_201FD7A30A4D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000022/0000310764-15-000022-index.htm.","url":"https://asof.is/claim/clm_201FD7A30A4D","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"614,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_201FD7A30A4D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2014, filed 2015-02-12"}},{"date":"2014-12-31","until":"2015-12-31","published":"2015-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 9,675,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_3DE9D6D92348, https://asof.is/claim/clm_3DE9D6D92348, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000022/0000310764-15-000022-index.htm.","url":"https://asof.is/claim/clm_3DE9D6D92348","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"9,675,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3DE9D6D92348","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2014, filed 2015-02-12"}},{"date":"2014-12-31","until":"2015-12-31","published":"2015-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 1,246,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_8BC108433968, https://asof.is/claim/clm_8BC108433968, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000022/0000310764-15-000022-index.htm.","url":"https://asof.is/claim/clm_8BC108433968","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"1,246,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8BC108433968","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2014, filed 2015-02-12"}},{"date":"2014-12-31","until":"2015-12-31","published":"2015-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 515,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_AE2E7B64D17E, https://asof.is/claim/clm_AE2E7B64D17E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000022/0000310764-15-000022-index.htm.","url":"https://asof.is/claim/clm_AE2E7B64D17E","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"515,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AE2E7B64D17E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2014, filed 2015-02-12"}},{"date":"2014-12-31","until":"2015-03-31","published":"2015-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 17,713,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_D7AFF104A930, https://asof.is/claim/clm_D7AFF104A930, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000022/0000310764-15-000022-index.htm.","url":"https://asof.is/claim/clm_D7AFF104A930","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"17,713,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D7AFF104A930","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2014, filed 2015-02-12"}},{"date":"2015-01-31","until":"2015-03-31","published":"2015-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 378,749,951 shares\", as of 2015-01-31 (until 2015-03-31). Claim clm_CA3C69B3E053, https://asof.is/claim/clm_CA3C69B3E053, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000022/0000310764-15-000022-index.htm.","url":"https://asof.is/claim/clm_CA3C69B3E053","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"378,749,951 shares","status":"superseded","assertable":true,"id":"clm_CA3C69B3E053","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2014, filed 2015-02-12"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 406,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_2CAB2726C660, https://asof.is/claim/clm_2CAB2726C660, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000074/0000310764-15-000074-index.htm.","url":"https://asof.is/claim/clm_2CAB2726C660","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"406,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2CAB2726C660","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2015, filed 2015-04-30"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 16,580,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_36B64A6B59F8, https://asof.is/claim/clm_36B64A6B59F8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000074/0000310764-15-000074-index.htm.","url":"https://asof.is/claim/clm_36B64A6B59F8","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"16,580,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_36B64A6B59F8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2015, filed 2015-04-30"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 378,409,144 shares\", as of 2015-03-31 (until 2015-06-30). Claim clm_3E41D88534B4, https://asof.is/claim/clm_3E41D88534B4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000074/0000310764-15-000074-index.htm.","url":"https://asof.is/claim/clm_3E41D88534B4","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"378,409,144 shares","status":"superseded","assertable":true,"id":"clm_3E41D88534B4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2015, filed 2015-04-30"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,674,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_4374CD94318E, https://asof.is/claim/clm_4374CD94318E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000074/0000310764-15-000074-index.htm.","url":"https://asof.is/claim/clm_4374CD94318E","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,674,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4374CD94318E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2015, filed 2015-04-30"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 224,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_787A7E62117C, https://asof.is/claim/clm_787A7E62117C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000074/0000310764-15-000074-index.htm.","url":"https://asof.is/claim/clm_787A7E62117C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"224,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_787A7E62117C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2015, filed 2015-04-30"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,379,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_8EBC6A8C2421, https://asof.is/claim/clm_8EBC6A8C2421, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000074/0000310764-15-000074-index.htm.","url":"https://asof.is/claim/clm_8EBC6A8C2421","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,379,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8EBC6A8C2421","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2015, filed 2015-04-30"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 152,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_9793D499B9D0, https://asof.is/claim/clm_9793D499B9D0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000074/0000310764-15-000074-index.htm.","url":"https://asof.is/claim/clm_9793D499B9D0","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"152,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9793D499B9D0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2015, filed 2015-04-30"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 8,321,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_A745B4A3EDF7, https://asof.is/claim/clm_A745B4A3EDF7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000074/0000310764-15-000074-index.htm.","url":"https://asof.is/claim/clm_A745B4A3EDF7","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"8,321,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A745B4A3EDF7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2015, filed 2015-04-30"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 16,819,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_09EA23E3ED9B, https://asof.is/claim/clm_09EA23E3ED9B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000109/0000310764-15-000109-index.htm.","url":"https://asof.is/claim/clm_09EA23E3ED9B","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"16,819,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_09EA23E3ED9B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2015, filed 2015-07-29"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 429,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_1645661E6806, https://asof.is/claim/clm_1645661E6806, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000109/0000310764-15-000109-index.htm.","url":"https://asof.is/claim/clm_1645661E6806","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"429,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1645661E6806","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2015, filed 2015-07-29"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 8,505,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_6040B1D3A809, https://asof.is/claim/clm_6040B1D3A809, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000109/0000310764-15-000109-index.htm.","url":"https://asof.is/claim/clm_6040B1D3A809","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"8,505,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6040B1D3A809","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2015, filed 2015-07-29"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 392,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_60A576B8E704, https://asof.is/claim/clm_60A576B8E704, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000109/0000310764-15-000109-index.htm.","url":"https://asof.is/claim/clm_60A576B8E704","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"392,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_60A576B8E704","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2015, filed 2015-07-29"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 376,558,214 shares\", as of 2015-06-30 (until 2015-09-30). Claim clm_8919BDA9CE99, https://asof.is/claim/clm_8919BDA9CE99, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000109/0000310764-15-000109-index.htm.","url":"https://asof.is/claim/clm_8919BDA9CE99","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"376,558,214 shares","status":"superseded","assertable":true,"id":"clm_8919BDA9CE99","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2015, filed 2015-07-29"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 154,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_BEB9661394D0, https://asof.is/claim/clm_BEB9661394D0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000109/0000310764-15-000109-index.htm.","url":"https://asof.is/claim/clm_BEB9661394D0","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"154,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BEB9661394D0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2015, filed 2015-07-29"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,432,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_BF4469A366D7, https://asof.is/claim/clm_BF4469A366D7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000109/0000310764-15-000109-index.htm.","url":"https://asof.is/claim/clm_BF4469A366D7","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,432,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BF4469A366D7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2015, filed 2015-07-29"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,626,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_DAF2722CC80F, https://asof.is/claim/clm_DAF2722CC80F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000109/0000310764-15-000109-index.htm.","url":"https://asof.is/claim/clm_DAF2722CC80F","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,626,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DAF2722CC80F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2015, filed 2015-07-29"}},{"date":"2015-09-30","until":"2016-03-31","published":"2015-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,420,000,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_052BEB810912, https://asof.is/claim/clm_052BEB810912, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000153/0000310764-15-000153-index.htm.","url":"https://asof.is/claim/clm_052BEB810912","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,420,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_052BEB810912","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2015, filed 2015-10-23"}},{"date":"2015-09-30","until":"2015-12-31","published":"2015-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 15,917,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_1BC06C67E514, https://asof.is/claim/clm_1BC06C67E514, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000153/0000310764-15-000153-index.htm.","url":"https://asof.is/claim/clm_1BC06C67E514","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"15,917,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1BC06C67E514","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2015, filed 2015-10-23"}},{"date":"2015-09-30","until":"2015-12-31","published":"2015-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,163,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_2710B4627E53, https://asof.is/claim/clm_2710B4627E53, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000153/0000310764-15-000153-index.htm.","url":"https://asof.is/claim/clm_2710B4627E53","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,163,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2710B4627E53","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2015, filed 2015-10-23"}},{"date":"2015-09-30","until":"2016-03-31","published":"2015-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 301,000,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_7A45C6D22A4A, https://asof.is/claim/clm_7A45C6D22A4A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000153/0000310764-15-000153-index.htm.","url":"https://asof.is/claim/clm_7A45C6D22A4A","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"301,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7A45C6D22A4A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2015, filed 2015-10-23"}},{"date":"2015-09-30","until":"2015-12-31","published":"2015-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 8,484,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_7DACB729FE50, https://asof.is/claim/clm_7DACB729FE50, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000153/0000310764-15-000153-index.htm.","url":"https://asof.is/claim/clm_7DACB729FE50","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"8,484,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7DACB729FE50","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2015, filed 2015-10-23"}},{"date":"2015-09-30","until":"2016-03-31","published":"2015-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 155,000,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_92E79C824790, https://asof.is/claim/clm_92E79C824790, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000153/0000310764-15-000153-index.htm.","url":"https://asof.is/claim/clm_92E79C824790","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"155,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_92E79C824790","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2015, filed 2015-10-23"}},{"date":"2015-09-30","until":"2016-03-31","published":"2015-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 378,000,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_C85B73F3E385, https://asof.is/claim/clm_C85B73F3E385, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000153/0000310764-15-000153-index.htm.","url":"https://asof.is/claim/clm_C85B73F3E385","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"378,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C85B73F3E385","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2015, filed 2015-10-23"}},{"date":"2015-09-30","until":"2016-01-31","published":"2015-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 375,522,232 shares\", as of 2015-09-30 (until 2016-01-31). Claim clm_CA7CC5A51A54, https://asof.is/claim/clm_CA7CC5A51A54, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076415000153/0000310764-15-000153-index.htm.","url":"https://asof.is/claim/clm_CA7CC5A51A54","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"375,522,232 shares","status":"superseded","assertable":true,"id":"clm_CA7CC5A51A54","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2015, filed 2015-10-23"}},{"date":"2015-12-31","until":"2016-12-31","published":"2016-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 9,946,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_16BDD523EAD1, https://asof.is/claim/clm_16BDD523EAD1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000226/0000310764-16-000226-index.htm.","url":"https://asof.is/claim/clm_16BDD523EAD1","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"9,946,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_16BDD523EAD1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2015, filed 2016-02-11"}},{"date":"2015-12-31","until":"2016-03-31","published":"2016-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 16,247,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_32C402698FB6, https://asof.is/claim/clm_32C402698FB6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000226/0000310764-16-000226-index.htm.","url":"https://asof.is/claim/clm_32C402698FB6","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"16,247,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_32C402698FB6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2015, filed 2016-02-11"}},{"date":"2015-12-31","until":"2016-03-31","published":"2016-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,379,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_6A9778D5707D, https://asof.is/claim/clm_6A9778D5707D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000226/0000310764-16-000226-index.htm.","url":"https://asof.is/claim/clm_6A9778D5707D","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,379,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6A9778D5707D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2016-02-11"}},{"date":"2015-12-31","until":"2016-03-31","published":"2016-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 8,511,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_A00FB1634E83, https://asof.is/claim/clm_A00FB1634E83, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000226/0000310764-16-000226-index.htm.","url":"https://asof.is/claim/clm_A00FB1634E83","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"8,511,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A00FB1634E83","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2015, filed 2016-02-11"}},{"date":"2015-12-31","until":"2016-12-31","published":"2016-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 625,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_B2943EF01993, https://asof.is/claim/clm_B2943EF01993, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000226/0000310764-16-000226-index.htm.","url":"https://asof.is/claim/clm_B2943EF01993","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"625,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B2943EF01993","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2015, filed 2016-02-11"}},{"date":"2015-12-31","until":"2016-12-31","published":"2016-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 1,861,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_D1CA23FA65BA, https://asof.is/claim/clm_D1CA23FA65BA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000226/0000310764-16-000226-index.htm.","url":"https://asof.is/claim/clm_D1CA23FA65BA","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"1,861,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D1CA23FA65BA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2015, filed 2016-02-11"}},{"date":"2015-12-31","until":"2016-12-31","published":"2016-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 1,439,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_F7DE11BA1021, https://asof.is/claim/clm_F7DE11BA1021, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000226/0000310764-16-000226-index.htm.","url":"https://asof.is/claim/clm_F7DE11BA1021","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"1,439,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F7DE11BA1021","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2015, filed 2016-02-11"}},{"date":"2016-01-31","until":"2016-03-31","published":"2016-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 372,982,213 shares\", as of 2016-01-31 (until 2016-03-31). Claim clm_9F390A54C7F5, https://asof.is/claim/clm_9F390A54C7F5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000226/0000310764-16-000226-index.htm.","url":"https://asof.is/claim/clm_9F390A54C7F5","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"372,982,213 shares","status":"superseded","assertable":true,"id":"clm_9F390A54C7F5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2015, filed 2016-02-11"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-04-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 6,976,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_0871F7FD189D, https://asof.is/claim/clm_0871F7FD189D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000320/0000310764-16-000320-index.htm.","url":"https://asof.is/claim/clm_0871F7FD189D","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"6,976,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0871F7FD189D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2016, filed 2016-04-22"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-04-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 519,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_1302D9D97099, https://asof.is/claim/clm_1302D9D97099, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000320/0000310764-16-000320-index.htm.","url":"https://asof.is/claim/clm_1302D9D97099","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"519,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1302D9D97099","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2016, filed 2016-04-22"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-04-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 8,808,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_2CDDE2F0211A, https://asof.is/claim/clm_2CDDE2F0211A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000320/0000310764-16-000320-index.htm.","url":"https://asof.is/claim/clm_2CDDE2F0211A","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"8,808,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2CDDE2F0211A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2016, filed 2016-04-22"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-04-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 159,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_2CE52D974E05, https://asof.is/claim/clm_2CE52D974E05, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000320/0000310764-16-000320-index.htm.","url":"https://asof.is/claim/clm_2CE52D974E05","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"159,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2CE52D974E05","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2016, filed 2016-04-22"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-04-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 19,668,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_50BF0E1CD1C0, https://asof.is/claim/clm_50BF0E1CD1C0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000320/0000310764-16-000320-index.htm.","url":"https://asof.is/claim/clm_50BF0E1CD1C0","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"19,668,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_50BF0E1CD1C0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2016, filed 2016-04-22"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-04-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 402,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_733F282C5241, https://asof.is/claim/clm_733F282C5241, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000320/0000310764-16-000320-index.htm.","url":"https://asof.is/claim/clm_733F282C5241","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"402,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_733F282C5241","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2016, filed 2016-04-22"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-04-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,495,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_A136A033A101, https://asof.is/claim/clm_A136A033A101, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000320/0000310764-16-000320-index.htm.","url":"https://asof.is/claim/clm_A136A033A101","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,495,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A136A033A101","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2016, filed 2016-04-22"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-04-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 373,981,097 shares\", as of 2016-03-31 (until 2016-06-30). Claim clm_CEB380DE69E5, https://asof.is/claim/clm_CEB380DE69E5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000320/0000310764-16-000320-index.htm.","url":"https://asof.is/claim/clm_CEB380DE69E5","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"373,981,097 shares","status":"superseded","assertable":true,"id":"clm_CEB380DE69E5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2016, filed 2016-04-22"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-07-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 500,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_10BD43968A49, https://asof.is/claim/clm_10BD43968A49, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000392/0000310764-16-000392-index.htm.","url":"https://asof.is/claim/clm_10BD43968A49","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"500,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_10BD43968A49","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2016, filed 2016-07-22"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-07-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,840,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_493669E0305E, https://asof.is/claim/clm_493669E0305E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000392/0000310764-16-000392-index.htm.","url":"https://asof.is/claim/clm_493669E0305E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,840,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_493669E0305E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2016, filed 2016-07-22"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-07-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,490,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_52A99F40BF80, https://asof.is/claim/clm_52A99F40BF80, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000392/0000310764-16-000392-index.htm.","url":"https://asof.is/claim/clm_52A99F40BF80","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,490,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_52A99F40BF80","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2016, filed 2016-07-22"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-07-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 20,520,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_5C7BDBEA0D9B, https://asof.is/claim/clm_5C7BDBEA0D9B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000392/0000310764-16-000392-index.htm.","url":"https://asof.is/claim/clm_5C7BDBEA0D9B","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"20,520,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5C7BDBEA0D9B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2016, filed 2016-07-22"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-07-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 374,302,065 shares\", as of 2016-06-30 (until 2016-09-30). Claim clm_701B83A4A7FC, https://asof.is/claim/clm_701B83A4A7FC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000392/0000310764-16-000392-index.htm.","url":"https://asof.is/claim/clm_701B83A4A7FC","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"374,302,065 shares","status":"superseded","assertable":true,"id":"clm_701B83A4A7FC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2016, filed 2016-07-22"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-07-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 380,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_955DEE6DFF5B, https://asof.is/claim/clm_955DEE6DFF5B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000392/0000310764-16-000392-index.htm.","url":"https://asof.is/claim/clm_955DEE6DFF5B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"380,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_955DEE6DFF5B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2016, filed 2016-07-22"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-07-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 183,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_B645460D7601, https://asof.is/claim/clm_B645460D7601, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000392/0000310764-16-000392-index.htm.","url":"https://asof.is/claim/clm_B645460D7601","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"183,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B645460D7601","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2016, filed 2016-07-22"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-07-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 9,098,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_E5A8D70F2FF4, https://asof.is/claim/clm_E5A8D70F2FF4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000392/0000310764-16-000392-index.htm.","url":"https://asof.is/claim/clm_E5A8D70F2FF4","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"9,098,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E5A8D70F2FF4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2016, filed 2016-07-22"}},{"date":"2016-09-30","until":"2017-03-31","published":"2016-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,833,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_0DC7620FE21A, https://asof.is/claim/clm_0DC7620FE21A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000458/0000310764-16-000458-index.htm.","url":"https://asof.is/claim/clm_0DC7620FE21A","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,833,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0DC7620FE21A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2016, filed 2016-10-28"}},{"date":"2016-09-30","until":"2016-12-31","published":"2016-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 2,953,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_15BC8332EE1A, https://asof.is/claim/clm_15BC8332EE1A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000458/0000310764-16-000458-index.htm.","url":"https://asof.is/claim/clm_15BC8332EE1A","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,953,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_15BC8332EE1A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2016, filed 2016-10-28"}},{"date":"2016-09-30","until":"2016-12-31","published":"2016-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 20,187,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_203A9967F9E6, https://asof.is/claim/clm_203A9967F9E6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000458/0000310764-16-000458-index.htm.","url":"https://asof.is/claim/clm_203A9967F9E6","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"20,187,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_203A9967F9E6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2016, filed 2016-10-28"}},{"date":"2016-09-30","until":"2017-03-31","published":"2016-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 486,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_69AAD42C607B, https://asof.is/claim/clm_69AAD42C607B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000458/0000310764-16-000458-index.htm.","url":"https://asof.is/claim/clm_69AAD42C607B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"486,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_69AAD42C607B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2016, filed 2016-10-28"}},{"date":"2016-09-30","until":"2016-12-31","published":"2016-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 9,332,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_A524BD28C56B, https://asof.is/claim/clm_A524BD28C56B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000458/0000310764-16-000458-index.htm.","url":"https://asof.is/claim/clm_A524BD28C56B","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"9,332,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A524BD28C56B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2016, filed 2016-10-28"}},{"date":"2016-09-30","until":"2017-03-31","published":"2016-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 184,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_AE2D35E2BF13, https://asof.is/claim/clm_AE2D35E2BF13, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000458/0000310764-16-000458-index.htm.","url":"https://asof.is/claim/clm_AE2D35E2BF13","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"184,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AE2D35E2BF13","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2016, filed 2016-10-28"}},{"date":"2016-09-30","until":"2017-03-31","published":"2016-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 355,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_CCBD317F41D5, https://asof.is/claim/clm_CCBD317F41D5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000458/0000310764-16-000458-index.htm.","url":"https://asof.is/claim/clm_CCBD317F41D5","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"355,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CCBD317F41D5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2016, filed 2016-10-28"}},{"date":"2016-09-30","until":"2017-01-31","published":"2016-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 374,451,718 shares\", as of 2016-09-30 (until 2017-01-31). Claim clm_D978BA6E96DB, https://asof.is/claim/clm_D978BA6E96DB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076416000458/0000310764-16-000458-index.htm.","url":"https://asof.is/claim/clm_D978BA6E96DB","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"374,451,718 shares","status":"superseded","assertable":true,"id":"clm_D978BA6E96DB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2016, filed 2016-10-28"}},{"date":"2016-12-31","until":"2017-12-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 715,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_0801EE9677F8, https://asof.is/claim/clm_0801EE9677F8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000034/0000310764-17-000034-index.htm.","url":"https://asof.is/claim/clm_0801EE9677F8","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"715,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0801EE9677F8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2016, filed 2017-02-09"}},{"date":"2016-12-31","until":"2017-03-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,316,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_39B59A4EFDC5, https://asof.is/claim/clm_39B59A4EFDC5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000034/0000310764-17-000034-index.htm.","url":"https://asof.is/claim/clm_39B59A4EFDC5","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,316,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_39B59A4EFDC5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2016, filed 2017-02-09"}},{"date":"2016-12-31","until":"2017-03-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 9,550,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_4437646C3CA3, https://asof.is/claim/clm_4437646C3CA3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000034/0000310764-17-000034-index.htm.","url":"https://asof.is/claim/clm_4437646C3CA3","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"9,550,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4437646C3CA3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2016, filed 2017-02-09"}},{"date":"2016-12-31","until":"2017-12-31","published":"2019-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 11,325,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_58F84D197D5C, https://asof.is/claim/clm_58F84D197D5C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000014/0000310764-19-000014-index.htm.","url":"https://asof.is/claim/clm_58F84D197D5C","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"11,325,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_58F84D197D5C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2018, filed 2019-02-07"}},{"date":"2016-12-31","until":"2017-12-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 1,647,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_D29CFA69B8E7, https://asof.is/claim/clm_D29CFA69B8E7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000034/0000310764-17-000034-index.htm.","url":"https://asof.is/claim/clm_D29CFA69B8E7","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"1,647,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D29CFA69B8E7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2016, filed 2017-02-09"}},{"date":"2016-12-31","until":"2017-12-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 2,166,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_E8D0D786058E, https://asof.is/claim/clm_E8D0D786058E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000034/0000310764-17-000034-index.htm.","url":"https://asof.is/claim/clm_E8D0D786058E","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"2,166,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E8D0D786058E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2016, filed 2017-02-09"}},{"date":"2016-12-31","until":"2017-03-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 20,435,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_ECF273ED40DE, https://asof.is/claim/clm_ECF273ED40DE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000034/0000310764-17-000034-index.htm.","url":"https://asof.is/claim/clm_ECF273ED40DE","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"20,435,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ECF273ED40DE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2016, filed 2017-02-09"}},{"date":"2017-01-31","until":"2017-03-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 372,878,298 shares\", as of 2017-01-31 (until 2017-03-31). Claim clm_EA5A297266CF, https://asof.is/claim/clm_EA5A297266CF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000034/0000310764-17-000034-index.htm.","url":"https://asof.is/claim/clm_EA5A297266CF","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"372,878,298 shares","status":"superseded","assertable":true,"id":"clm_EA5A297266CF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2016, filed 2017-02-09"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 373,765,028 shares\", as of 2017-03-31 (until 2017-06-30). Claim clm_0996F2BEA8A0, https://asof.is/claim/clm_0996F2BEA8A0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000102/0000310764-17-000102-index.htm.","url":"https://asof.is/claim/clm_0996F2BEA8A0","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"373,765,028 shares","status":"superseded","assertable":true,"id":"clm_0996F2BEA8A0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2017, filed 2017-04-27"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 444,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_3AD239BC34C0, https://asof.is/claim/clm_3AD239BC34C0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000102/0000310764-17-000102-index.htm.","url":"https://asof.is/claim/clm_3AD239BC34C0","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"444,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3AD239BC34C0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2017, filed 2017-04-27"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 554,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_7A6E49883616, https://asof.is/claim/clm_7A6E49883616, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000102/0000310764-17-000102-index.htm.","url":"https://asof.is/claim/clm_7A6E49883616","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"554,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7A6E49883616","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2017, filed 2017-04-27"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 9,704,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_B8FF9A76AD06, https://asof.is/claim/clm_B8FF9A76AD06, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000102/0000310764-17-000102-index.htm.","url":"https://asof.is/claim/clm_B8FF9A76AD06","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"9,704,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B8FF9A76AD06","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2017, filed 2017-04-27"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,213,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_C48CEE54DDD9, https://asof.is/claim/clm_C48CEE54DDD9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000102/0000310764-17-000102-index.htm.","url":"https://asof.is/claim/clm_C48CEE54DDD9","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,213,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C48CEE54DDD9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2017, filed 2017-04-27"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 20,517,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_CFF879E402FC, https://asof.is/claim/clm_CFF879E402FC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000102/0000310764-17-000102-index.htm.","url":"https://asof.is/claim/clm_CFF879E402FC","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"20,517,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CFF879E402FC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2017, filed 2017-04-27"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 192,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_D96D0580D8AE, https://asof.is/claim/clm_D96D0580D8AE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000102/0000310764-17-000102-index.htm.","url":"https://asof.is/claim/clm_D96D0580D8AE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"192,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D96D0580D8AE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2017, filed 2017-04-27"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,955,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_E1E5ACA01AA8, https://asof.is/claim/clm_E1E5ACA01AA8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000102/0000310764-17-000102-index.htm.","url":"https://asof.is/claim/clm_E1E5ACA01AA8","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,955,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E1E5ACA01AA8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2017, filed 2017-04-27"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 391,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_055D092DC8C5, https://asof.is/claim/clm_055D092DC8C5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000136/0000310764-17-000136-index.htm.","url":"https://asof.is/claim/clm_055D092DC8C5","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"391,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_055D092DC8C5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2017, filed 2017-07-28"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 192,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_594FA442E545, https://asof.is/claim/clm_594FA442E545, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000136/0000310764-17-000136-index.htm.","url":"https://asof.is/claim/clm_594FA442E545","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"192,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_594FA442E545","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2017, filed 2017-07-28"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,649,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_596DA70D2728, https://asof.is/claim/clm_596DA70D2728, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000136/0000310764-17-000136-index.htm.","url":"https://asof.is/claim/clm_596DA70D2728","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,649,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_596DA70D2728","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2017, filed 2017-07-28"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 10,035,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_8CD419311E75, https://asof.is/claim/clm_8CD419311E75, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000136/0000310764-17-000136-index.htm.","url":"https://asof.is/claim/clm_8CD419311E75","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"10,035,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8CD419311E75","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2017, filed 2017-07-28"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 3,012,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_B5F9D8DF2B89, https://asof.is/claim/clm_B5F9D8DF2B89, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000136/0000310764-17-000136-index.htm.","url":"https://asof.is/claim/clm_B5F9D8DF2B89","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"3,012,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B5F9D8DF2B89","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2017, filed 2017-07-28"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 374,063,294 shares\", as of 2017-06-30 (until 2017-09-30). Claim clm_B949C2573D52, https://asof.is/claim/clm_B949C2573D52, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000136/0000310764-17-000136-index.htm.","url":"https://asof.is/claim/clm_B949C2573D52","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"374,063,294 shares","status":"superseded","assertable":true,"id":"clm_B949C2573D52","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2017, filed 2017-07-28"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 501,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_E51FAE9170BB, https://asof.is/claim/clm_E51FAE9170BB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000136/0000310764-17-000136-index.htm.","url":"https://asof.is/claim/clm_E51FAE9170BB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"501,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E51FAE9170BB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2017, filed 2017-07-28"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 21,292,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_F3475369B4F0, https://asof.is/claim/clm_F3475369B4F0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000136/0000310764-17-000136-index.htm.","url":"https://asof.is/claim/clm_F3475369B4F0","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"21,292,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F3475369B4F0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2017, filed 2017-07-28"}},{"date":"2017-09-30","until":"2017-12-31","published":"2017-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 2,592,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_0C15D130D6E0, https://asof.is/claim/clm_0C15D130D6E0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000164/0000310764-17-000164-index.htm.","url":"https://asof.is/claim/clm_0C15D130D6E0","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,592,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0C15D130D6E0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2017, filed 2017-10-27"}},{"date":"2017-09-30","until":"2018-03-31","published":"2017-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 434,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_466868801F25, https://asof.is/claim/clm_466868801F25, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000164/0000310764-17-000164-index.htm.","url":"https://asof.is/claim/clm_466868801F25","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"434,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_466868801F25","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2017, filed 2017-10-27"}},{"date":"2017-09-30","until":"2018-01-31","published":"2017-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 374,237,631 shares\", as of 2017-09-30 (until 2018-01-31). Claim clm_510DA84D7642, https://asof.is/claim/clm_510DA84D7642, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000164/0000310764-17-000164-index.htm.","url":"https://asof.is/claim/clm_510DA84D7642","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"374,237,631 shares","status":"superseded","assertable":true,"id":"clm_510DA84D7642","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2017, filed 2017-10-27"}},{"date":"2017-09-30","until":"2017-12-31","published":"2017-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 21,485,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_7D68CEE62CF1, https://asof.is/claim/clm_7D68CEE62CF1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000164/0000310764-17-000164-index.htm.","url":"https://asof.is/claim/clm_7D68CEE62CF1","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"21,485,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7D68CEE62CF1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2017, filed 2017-10-27"}},{"date":"2017-09-30","until":"2017-12-31","published":"2017-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 10,425,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_814865ADE6EB, https://asof.is/claim/clm_814865ADE6EB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000164/0000310764-17-000164-index.htm.","url":"https://asof.is/claim/clm_814865ADE6EB","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"10,425,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_814865ADE6EB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2017, filed 2017-10-27"}},{"date":"2017-09-30","until":"2018-03-31","published":"2017-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 523,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_81A618C4C94F, https://asof.is/claim/clm_81A618C4C94F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000164/0000310764-17-000164-index.htm.","url":"https://asof.is/claim/clm_81A618C4C94F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"523,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_81A618C4C94F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2017, filed 2017-10-27"}},{"date":"2017-09-30","until":"2018-03-31","published":"2018-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 3,006,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_A759926B3451, https://asof.is/claim/clm_A759926B3451, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000205/0000310764-18-000205-index.htm.","url":"https://asof.is/claim/clm_A759926B3451","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"3,006,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A759926B3451","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2018, filed 2018-10-26"}},{"date":"2017-09-30","until":"2018-03-31","published":"2017-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 198,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_CC654750CF9D, https://asof.is/claim/clm_CC654750CF9D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076417000164/0000310764-17-000164-index.htm.","url":"https://asof.is/claim/clm_CC654750CF9D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"198,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CC654750CF9D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2017, filed 2017-10-27"}},{"date":"2017-12-31","until":"2018-03-31","published":"2018-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 22,197,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_010921C47955, https://asof.is/claim/clm_010921C47955, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000031/0000310764-18-000031-index.htm.","url":"https://asof.is/claim/clm_010921C47955","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"22,197,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_010921C47955","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2017, filed 2018-02-08"}},{"date":"2017-12-31","until":"2018-03-31","published":"2018-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 9,966,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_6D31F2D60BFC, https://asof.is/claim/clm_6D31F2D60BFC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000031/0000310764-18-000031-index.htm.","url":"https://asof.is/claim/clm_6D31F2D60BFC","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"9,966,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6D31F2D60BFC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2017, filed 2018-02-08"}},{"date":"2017-12-31","until":"2018-12-31","published":"2018-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 787,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_7F4B9C2ED4BE, https://asof.is/claim/clm_7F4B9C2ED4BE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000031/0000310764-18-000031-index.htm.","url":"https://asof.is/claim/clm_7F4B9C2ED4BE","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"787,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7F4B9C2ED4BE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2017, filed 2018-02-08"}},{"date":"2017-12-31","until":"2018-12-31","published":"2018-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 2,290,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_973121336500, https://asof.is/claim/clm_973121336500, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000031/0000310764-18-000031-index.htm.","url":"https://asof.is/claim/clm_973121336500","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"2,290,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_973121336500","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2017, filed 2018-02-08"}},{"date":"2017-12-31","until":"2018-12-31","published":"2019-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 12,444,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_9BFEAF075BD7, https://asof.is/claim/clm_9BFEAF075BD7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000014/0000310764-19-000014-index.htm.","url":"https://asof.is/claim/clm_9BFEAF075BD7","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"12,444,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9BFEAF075BD7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2018, filed 2019-02-07"}},{"date":"2017-12-31","until":"2018-12-31","published":"2018-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 1,020,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_B9E4D0FB04B9, https://asof.is/claim/clm_B9E4D0FB04B9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000031/0000310764-18-000031-index.htm.","url":"https://asof.is/claim/clm_B9E4D0FB04B9","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"1,020,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B9E4D0FB04B9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2017, filed 2018-02-08"}},{"date":"2017-12-31","until":"2018-03-31","published":"2018-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 2,542,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_D3C2F4A0EC89, https://asof.is/claim/clm_D3C2F4A0EC89, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000031/0000310764-18-000031-index.htm.","url":"https://asof.is/claim/clm_D3C2F4A0EC89","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,542,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D3C2F4A0EC89","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2017, filed 2018-02-08"}},{"date":"2018-01-31","until":"2018-03-31","published":"2018-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 374,642,060 shares\", as of 2018-01-31 (until 2018-03-31). Claim clm_BFD03FBC0513, https://asof.is/claim/clm_BFD03FBC0513, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000031/0000310764-18-000031-index.htm.","url":"https://asof.is/claim/clm_BFD03FBC0513","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"374,642,060 shares","status":"superseded","assertable":true,"id":"clm_BFD03FBC0513","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2017, filed 2018-02-08"}},{"date":"2018-03-31","until":"2018-06-30","published":"2019-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 3,241,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_142C5B14FF64, https://asof.is/claim/clm_142C5B14FF64, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000071/0000310764-19-000071-index.htm.","url":"https://asof.is/claim/clm_142C5B14FF64","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"3,241,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_142C5B14FF64","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2019, filed 2019-04-24"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 591,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_3AD1A4CBA10A, https://asof.is/claim/clm_3AD1A4CBA10A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000110/0000310764-18-000110-index.htm.","url":"https://asof.is/claim/clm_3AD1A4CBA10A","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"591,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3AD1A4CBA10A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2018, filed 2018-04-27"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 204,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_4B212838AA2B, https://asof.is/claim/clm_4B212838AA2B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000110/0000310764-18-000110-index.htm.","url":"https://asof.is/claim/clm_4B212838AA2B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"204,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4B212838AA2B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2018, filed 2018-04-27"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 443,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_8C8DF1FE9B53, https://asof.is/claim/clm_8C8DF1FE9B53, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000110/0000310764-18-000110-index.htm.","url":"https://asof.is/claim/clm_8C8DF1FE9B53","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"443,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8C8DF1FE9B53","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2018, filed 2018-04-27"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 373,710,934 shares\", as of 2018-03-31 (until 2018-06-30). Claim clm_9FF400C7E1DF, https://asof.is/claim/clm_9FF400C7E1DF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000110/0000310764-18-000110-index.htm.","url":"https://asof.is/claim/clm_9FF400C7E1DF","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"373,710,934 shares","status":"superseded","assertable":true,"id":"clm_9FF400C7E1DF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2018, filed 2018-04-27"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 9,214,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_C01BCE9D3CDA, https://asof.is/claim/clm_C01BCE9D3CDA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000110/0000310764-18-000110-index.htm.","url":"https://asof.is/claim/clm_C01BCE9D3CDA","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"9,214,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C01BCE9D3CDA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2018, filed 2018-04-27"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 2,179,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_C9B4B85611CE, https://asof.is/claim/clm_C9B4B85611CE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000110/0000310764-18-000110-index.htm.","url":"https://asof.is/claim/clm_C9B4B85611CE","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,179,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C9B4B85611CE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2018, filed 2018-04-27"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-04-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 22,133,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_F23E44A49BA5, https://asof.is/claim/clm_F23E44A49BA5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000110/0000310764-18-000110-index.htm.","url":"https://asof.is/claim/clm_F23E44A49BA5","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"22,133,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F23E44A49BA5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2018, filed 2018-04-27"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 452,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_166DA739B7B2, https://asof.is/claim/clm_166DA739B7B2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000185/0000310764-18-000185-index.htm.","url":"https://asof.is/claim/clm_166DA739B7B2","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"452,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_166DA739B7B2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2018, filed 2018-07-25"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 216,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_206E9EB6274E, https://asof.is/claim/clm_206E9EB6274E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000185/0000310764-18-000185-index.htm.","url":"https://asof.is/claim/clm_206E9EB6274E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"216,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_206E9EB6274E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2018, filed 2018-07-25"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,641,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_3D8A982E7366, https://asof.is/claim/clm_3D8A982E7366, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000185/0000310764-18-000185-index.htm.","url":"https://asof.is/claim/clm_3D8A982E7366","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,641,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3D8A982E7366","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2018, filed 2018-07-25"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 373,990,494 shares\", as of 2018-06-30 (until 2018-09-30). Claim clm_44ED08B99453, https://asof.is/claim/clm_44ED08B99453, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000185/0000310764-18-000185-index.htm.","url":"https://asof.is/claim/clm_44ED08B99453","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"373,990,494 shares","status":"superseded","assertable":true,"id":"clm_44ED08B99453","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2018, filed 2018-07-25"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 672,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_5B64A27065C5, https://asof.is/claim/clm_5B64A27065C5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000185/0000310764-18-000185-index.htm.","url":"https://asof.is/claim/clm_5B64A27065C5","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"672,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5B64A27065C5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2018, filed 2018-07-25"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 21,570,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_6D2B6F006ED8, https://asof.is/claim/clm_6D2B6F006ED8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000185/0000310764-18-000185-index.htm.","url":"https://asof.is/claim/clm_6D2B6F006ED8","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"21,570,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6D2B6F006ED8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2018, filed 2018-07-25"}},{"date":"2018-06-30","until":"2018-09-30","published":"2019-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 3,322,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_7A6FC6AA3A0D, https://asof.is/claim/clm_7A6FC6AA3A0D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000110/0000310764-19-000110-index.htm.","url":"https://asof.is/claim/clm_7A6FC6AA3A0D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"3,322,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7A6FC6AA3A0D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2019, filed 2019-07-26"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 9,460,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_9C75DAF3D2C6, https://asof.is/claim/clm_9C75DAF3D2C6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000185/0000310764-18-000185-index.htm.","url":"https://asof.is/claim/clm_9C75DAF3D2C6","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"9,460,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9C75DAF3D2C6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2018, filed 2018-07-25"}},{"date":"2018-09-30","until":"2019-03-31","published":"2018-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 576,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_0E44C321583C, https://asof.is/claim/clm_0E44C321583C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000205/0000310764-18-000205-index.htm.","url":"https://asof.is/claim/clm_0E44C321583C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"576,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0E44C321583C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2018, filed 2018-10-26"}},{"date":"2018-09-30","until":"2018-12-31","published":"2018-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 9,860,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_566414C3D6BC, https://asof.is/claim/clm_566414C3D6BC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000205/0000310764-18-000205-index.htm.","url":"https://asof.is/claim/clm_566414C3D6BC","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"9,860,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_566414C3D6BC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2018, filed 2018-10-26"}},{"date":"2018-09-30","until":"2018-12-31","published":"2018-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,918,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_7285977DFCF5, https://asof.is/claim/clm_7285977DFCF5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000205/0000310764-18-000205-index.htm.","url":"https://asof.is/claim/clm_7285977DFCF5","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,918,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7285977DFCF5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2018, filed 2018-10-26"}},{"date":"2018-09-30","until":"2019-03-31","published":"2018-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 221,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_73A846750188, https://asof.is/claim/clm_73A846750188, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000205/0000310764-18-000205-index.htm.","url":"https://asof.is/claim/clm_73A846750188","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"221,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_73A846750188","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2018, filed 2018-10-26"}},{"date":"2018-09-30","until":"2018-12-31","published":"2018-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 22,084,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_8E9B851AB69C, https://asof.is/claim/clm_8E9B851AB69C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000205/0000310764-18-000205-index.htm.","url":"https://asof.is/claim/clm_8E9B851AB69C","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"22,084,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8E9B851AB69C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2018, filed 2018-10-26"}},{"date":"2018-09-30","until":"2019-01-31","published":"2018-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 374,187,286 shares\", as of 2018-09-30 (until 2019-01-31). Claim clm_915336B6D6A5, https://asof.is/claim/clm_915336B6D6A5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000205/0000310764-18-000205-index.htm.","url":"https://asof.is/claim/clm_915336B6D6A5","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"374,187,286 shares","status":"superseded","assertable":true,"id":"clm_915336B6D6A5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2018, filed 2018-10-26"}},{"date":"2018-09-30","until":"2019-03-31","published":"2018-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 3,242,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_AC5A5FE8C379, https://asof.is/claim/clm_AC5A5FE8C379, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000205/0000310764-18-000205-index.htm.","url":"https://asof.is/claim/clm_AC5A5FE8C379","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"3,242,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AC5A5FE8C379","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2018, filed 2018-10-26"}},{"date":"2018-09-30","until":"2019-03-31","published":"2018-10-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 590,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_E36DC7AE334F, https://asof.is/claim/clm_E36DC7AE334F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076418000205/0000310764-18-000205-index.htm.","url":"https://asof.is/claim/clm_E36DC7AE334F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"590,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E36DC7AE334F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2018, filed 2018-10-26"}},{"date":"2018-12-31","until":"2019-03-31","published":"2019-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 11,730,000,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_5E7F4020F1BF, https://asof.is/claim/clm_5E7F4020F1BF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000014/0000310764-19-000014-index.htm.","url":"https://asof.is/claim/clm_5E7F4020F1BF","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"11,730,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5E7F4020F1BF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2018, filed 2019-02-07"}},{"date":"2018-12-31","until":"2019-03-31","published":"2019-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,616,000,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_6B2772627E1D, https://asof.is/claim/clm_6B2772627E1D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000014/0000310764-19-000014-index.htm.","url":"https://asof.is/claim/clm_6B2772627E1D","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,616,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6B2772627E1D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2018, filed 2019-02-07"}},{"date":"2018-12-31","until":"2019-03-31","published":"2019-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 27,229,000,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_6F9CD19E5F26, https://asof.is/claim/clm_6F9CD19E5F26, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000014/0000310764-19-000014-index.htm.","url":"https://asof.is/claim/clm_6F9CD19E5F26","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"27,229,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6F9CD19E5F26","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2018, filed 2019-02-07"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 862,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_A81B190AB431, https://asof.is/claim/clm_A81B190AB431, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000014/0000310764-19-000014-index.htm.","url":"https://asof.is/claim/clm_A81B190AB431","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"862,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A81B190AB431","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2018, filed 2019-02-07"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 3,553,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_AC674EC5E637, https://asof.is/claim/clm_AC674EC5E637, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000014/0000310764-19-000014-index.htm.","url":"https://asof.is/claim/clm_AC674EC5E637","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"3,553,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AC674EC5E637","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2018, filed 2019-02-07"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 2,537,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_ECD0BBBBB93A, https://asof.is/claim/clm_ECD0BBBBB93A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000014/0000310764-19-000014-index.htm.","url":"https://asof.is/claim/clm_ECD0BBBBB93A","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"2,537,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ECD0BBBBB93A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2018, filed 2019-02-07"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 13,601,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_FEE1B8FE886A, https://asof.is/claim/clm_FEE1B8FE886A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000014/0000310764-19-000014-index.htm.","url":"https://asof.is/claim/clm_FEE1B8FE886A","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"13,601,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FEE1B8FE886A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2018, filed 2019-02-07"}},{"date":"2019-01-31","until":"2019-03-31","published":"2019-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 372,664,636 shares\", as of 2019-01-31 (until 2019-03-31). Claim clm_23346F5EE82C, https://asof.is/claim/clm_23346F5EE82C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000014/0000310764-19-000014-index.htm.","url":"https://asof.is/claim/clm_23346F5EE82C","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"372,664,636 shares","status":"superseded","assertable":true,"id":"clm_23346F5EE82C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2018, filed 2019-02-07"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,674,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_0EA4EE5B90FD, https://asof.is/claim/clm_0EA4EE5B90FD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000071/0000310764-19-000071-index.htm.","url":"https://asof.is/claim/clm_0EA4EE5B90FD","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,674,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0EA4EE5B90FD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2019, filed 2019-04-24"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 528,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_29213B492FBA, https://asof.is/claim/clm_29213B492FBA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000071/0000310764-19-000071-index.htm.","url":"https://asof.is/claim/clm_29213B492FBA","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"528,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_29213B492FBA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2019, filed 2019-04-24"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 25,937,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_2DCDB4D708B9, https://asof.is/claim/clm_2DCDB4D708B9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000071/0000310764-19-000071-index.htm.","url":"https://asof.is/claim/clm_2DCDB4D708B9","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"25,937,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2DCDB4D708B9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2019, filed 2019-04-24"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 412,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_384806036872, https://asof.is/claim/clm_384806036872, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000071/0000310764-19-000071-index.htm.","url":"https://asof.is/claim/clm_384806036872","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"412,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_384806036872","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2019, filed 2019-04-24"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 373,810,085 shares\", as of 2019-03-31 (until 2019-06-30). Claim clm_CA2DCEB73089, https://asof.is/claim/clm_CA2DCEB73089, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000071/0000310764-19-000071-index.htm.","url":"https://asof.is/claim/clm_CA2DCEB73089","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"373,810,085 shares","status":"superseded","assertable":true,"id":"clm_CA2DCEB73089","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2019, filed 2019-04-24"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 225,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_CF30656403F2, https://asof.is/claim/clm_CF30656403F2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000071/0000310764-19-000071-index.htm.","url":"https://asof.is/claim/clm_CF30656403F2","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"225,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CF30656403F2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2019, filed 2019-04-24"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 3,516,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_F8CF3FE59B06, https://asof.is/claim/clm_F8CF3FE59B06, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000071/0000310764-19-000071-index.htm.","url":"https://asof.is/claim/clm_F8CF3FE59B06","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"3,516,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F8CF3FE59B06","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2019, filed 2019-04-24"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-04-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 11,693,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_F93FF9F4D1B5, https://asof.is/claim/clm_F93FF9F4D1B5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000071/0000310764-19-000071-index.htm.","url":"https://asof.is/claim/clm_F93FF9F4D1B5","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"11,693,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F93FF9F4D1B5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2019, filed 2019-04-24"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 374,103,607 shares\", as of 2019-06-30 (until 2019-09-30). Claim clm_07C3C1DAD9A7, https://asof.is/claim/clm_07C3C1DAD9A7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000110/0000310764-19-000110-index.htm.","url":"https://asof.is/claim/clm_07C3C1DAD9A7","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"374,103,607 shares","status":"superseded","assertable":true,"id":"clm_07C3C1DAD9A7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2019, filed 2019-07-26"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 246,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_239E1A748D21, https://asof.is/claim/clm_239E1A748D21, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000110/0000310764-19-000110-index.htm.","url":"https://asof.is/claim/clm_239E1A748D21","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"246,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_239E1A748D21","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2019, filed 2019-07-26"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 3,650,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_3BA2EF6C85D5, https://asof.is/claim/clm_3BA2EF6C85D5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000110/0000310764-19-000110-index.htm.","url":"https://asof.is/claim/clm_3BA2EF6C85D5","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"3,650,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3BA2EF6C85D5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2019, filed 2019-07-26"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 26,354,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_6B113DE4A2AF, https://asof.is/claim/clm_6B113DE4A2AF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000110/0000310764-19-000110-index.htm.","url":"https://asof.is/claim/clm_6B113DE4A2AF","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"26,354,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6B113DE4A2AF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2019, filed 2019-07-26"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 11,943,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_97666EB6E30A, https://asof.is/claim/clm_97666EB6E30A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000110/0000310764-19-000110-index.htm.","url":"https://asof.is/claim/clm_97666EB6E30A","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"11,943,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_97666EB6E30A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2019, filed 2019-07-26"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,754,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_9A74657D6E43, https://asof.is/claim/clm_9A74657D6E43, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000110/0000310764-19-000110-index.htm.","url":"https://asof.is/claim/clm_9A74657D6E43","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,754,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9A74657D6E43","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2019, filed 2019-07-26"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 613,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_B09C4F8856EC, https://asof.is/claim/clm_B09C4F8856EC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000110/0000310764-19-000110-index.htm.","url":"https://asof.is/claim/clm_B09C4F8856EC","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"613,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B09C4F8856EC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2019, filed 2019-07-26"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-07-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 480,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_B24CA9162373, https://asof.is/claim/clm_B24CA9162373, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000110/0000310764-19-000110-index.htm.","url":"https://asof.is/claim/clm_B24CA9162373","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"480,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B24CA9162373","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2019, filed 2019-07-26"}},{"date":"2019-09-30","until":"2020-01-31","published":"2019-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 374,366,776 shares\", as of 2019-09-30 (until 2020-01-31). Claim clm_22D6CF4CF3C3, https://asof.is/claim/clm_22D6CF4CF3C3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000140/0000310764-19-000140-index.htm.","url":"https://asof.is/claim/clm_22D6CF4CF3C3","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"374,366,776 shares","status":"superseded","assertable":true,"id":"clm_22D6CF4CF3C3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2019, filed 2019-10-30"}},{"date":"2019-09-30","until":"2019-12-31","published":"2019-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 26,659,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_53949DBBDCB2, https://asof.is/claim/clm_53949DBBDCB2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000140/0000310764-19-000140-index.htm.","url":"https://asof.is/claim/clm_53949DBBDCB2","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"26,659,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_53949DBBDCB2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2019, filed 2019-10-30"}},{"date":"2019-09-30","until":"2020-03-31","published":"2019-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 628,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_668BD7ECC768, https://asof.is/claim/clm_668BD7ECC768, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000140/0000310764-19-000140-index.htm.","url":"https://asof.is/claim/clm_668BD7ECC768","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"628,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_668BD7ECC768","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2019, filed 2019-10-30"}},{"date":"2019-09-30","until":"2019-12-31","published":"2019-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 12,315,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_85F26113485E, https://asof.is/claim/clm_85F26113485E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000140/0000310764-19-000140-index.htm.","url":"https://asof.is/claim/clm_85F26113485E","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"12,315,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_85F26113485E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2019, filed 2019-10-30"}},{"date":"2019-09-30","until":"2020-03-31","published":"2019-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 466,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_975D0688D0C3, https://asof.is/claim/clm_975D0688D0C3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000140/0000310764-19-000140-index.htm.","url":"https://asof.is/claim/clm_975D0688D0C3","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"466,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_975D0688D0C3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2019, filed 2019-10-30"}},{"date":"2019-09-30","until":"2019-12-31","published":"2019-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,948,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_A12DB475C05B, https://asof.is/claim/clm_A12DB475C05B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000140/0000310764-19-000140-index.htm.","url":"https://asof.is/claim/clm_A12DB475C05B","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,948,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A12DB475C05B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2019, filed 2019-10-30"}},{"date":"2019-09-30","until":"2020-03-31","published":"2019-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 246,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_D28BC8D99637, https://asof.is/claim/clm_D28BC8D99637, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000140/0000310764-19-000140-index.htm.","url":"https://asof.is/claim/clm_D28BC8D99637","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"246,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D28BC8D99637","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2019, filed 2019-10-30"}},{"date":"2019-09-30","until":"2020-03-31","published":"2019-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 3,587,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_FE7CC48A90F2, https://asof.is/claim/clm_FE7CC48A90F2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076419000140/0000310764-19-000140-index.htm.","url":"https://asof.is/claim/clm_FE7CC48A90F2","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"3,587,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FE7CC48A90F2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2019, filed 2019-10-30"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-02-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 971,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_0311707603F7, https://asof.is/claim/clm_0311707603F7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000014/0000310764-20-000014-index.htm.","url":"https://asof.is/claim/clm_0311707603F7","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"971,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0311707603F7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2019, filed 2020-02-06"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-02-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 14,884,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_2C46D5976B3D, https://asof.is/claim/clm_2C46D5976B3D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000014/0000310764-20-000014-index.htm.","url":"https://asof.is/claim/clm_2C46D5976B3D","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"14,884,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2C46D5976B3D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2019, filed 2020-02-06"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-02-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 2,713,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_39F85B65BE8F, https://asof.is/claim/clm_39F85B65BE8F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000014/0000310764-20-000014-index.htm.","url":"https://asof.is/claim/clm_39F85B65BE8F","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"2,713,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_39F85B65BE8F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2019, filed 2020-02-06"}},{"date":"2019-12-31","until":"2020-03-31","published":"2020-02-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 30,167,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_3FDCC73DC863, https://asof.is/claim/clm_3FDCC73DC863, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000014/0000310764-20-000014-index.htm.","url":"https://asof.is/claim/clm_3FDCC73DC863","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"30,167,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3FDCC73DC863","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2019, filed 2020-02-06"}},{"date":"2019-12-31","until":"2020-03-31","published":"2020-02-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 4,337,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_86730892E081, https://asof.is/claim/clm_86730892E081, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000014/0000310764-20-000014-index.htm.","url":"https://asof.is/claim/clm_86730892E081","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"4,337,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_86730892E081","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2019, filed 2020-02-06"}},{"date":"2019-12-31","until":"2020-03-31","published":"2020-02-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 12,807,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_9CF5786BE862, https://asof.is/claim/clm_9CF5786BE862, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000014/0000310764-20-000014-index.htm.","url":"https://asof.is/claim/clm_9CF5786BE862","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"12,807,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9CF5786BE862","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2019, filed 2020-02-06"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-02-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 2,083,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_C0FD8BF73574, https://asof.is/claim/clm_C0FD8BF73574, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000014/0000310764-20-000014-index.htm.","url":"https://asof.is/claim/clm_C0FD8BF73574","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"2,083,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C0FD8BF73574","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2019, filed 2020-02-06"}},{"date":"2020-01-31","until":"2020-03-31","published":"2020-02-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 374,575,145 shares\", as of 2020-01-31 (until 2020-03-31). Claim clm_96965895C9BE, https://asof.is/claim/clm_96965895C9BE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000014/0000310764-20-000014-index.htm.","url":"https://asof.is/claim/clm_96965895C9BE","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"374,575,145 shares","status":"superseded","assertable":true,"id":"clm_96965895C9BE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2019, filed 2020-02-06"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 375,378,477 shares\", as of 2020-03-31 (until 2020-06-30). Claim clm_10215670F765, https://asof.is/claim/clm_10215670F765, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000069/0000310764-20-000069-index.htm.","url":"https://asof.is/claim/clm_10215670F765","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"375,378,477 shares","status":"superseded","assertable":true,"id":"clm_10215670F765","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2020, filed 2020-05-01"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 493,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_25315F1D0718, https://asof.is/claim/clm_25315F1D0718, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000069/0000310764-20-000069-index.htm.","url":"https://asof.is/claim/clm_25315F1D0718","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"493,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_25315F1D0718","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2020, filed 2020-05-01"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 254,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_404F7B5A8D4B, https://asof.is/claim/clm_404F7B5A8D4B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000069/0000310764-20-000069-index.htm.","url":"https://asof.is/claim/clm_404F7B5A8D4B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"254,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_404F7B5A8D4B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2020, filed 2020-05-01"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 29,440,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_49C6D2132BDA, https://asof.is/claim/clm_49C6D2132BDA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000069/0000310764-20-000069-index.htm.","url":"https://asof.is/claim/clm_49C6D2132BDA","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"29,440,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_49C6D2132BDA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2020, filed 2020-05-01"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 13,115,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_529F6920E490, https://asof.is/claim/clm_529F6920E490, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000069/0000310764-20-000069-index.htm.","url":"https://asof.is/claim/clm_529F6920E490","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"13,115,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_529F6920E490","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2020, filed 2020-05-01"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 3,588,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_D86C65F9DE3F, https://asof.is/claim/clm_D86C65F9DE3F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000069/0000310764-20-000069-index.htm.","url":"https://asof.is/claim/clm_D86C65F9DE3F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"3,588,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D86C65F9DE3F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2020, filed 2020-05-01"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 635,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_F2254CE46C4C, https://asof.is/claim/clm_F2254CE46C4C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000069/0000310764-20-000069-index.htm.","url":"https://asof.is/claim/clm_F2254CE46C4C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"635,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F2254CE46C4C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2020, filed 2020-05-01"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,964,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_F3B2E129D1A4, https://asof.is/claim/clm_F3B2E129D1A4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000069/0000310764-20-000069-index.htm.","url":"https://asof.is/claim/clm_F3B2E129D1A4","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,964,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F3B2E129D1A4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2020, filed 2020-05-01"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 375,605,813 shares\", as of 2020-06-30 (until 2020-09-30). Claim clm_1F201B828161, https://asof.is/claim/clm_1F201B828161, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000125/0000310764-20-000125-index.htm.","url":"https://asof.is/claim/clm_1F201B828161","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"375,605,813 shares","status":"superseded","assertable":true,"id":"clm_1F201B828161","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2020, filed 2020-07-31"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 233,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_36F0B3E6D922, https://asof.is/claim/clm_36F0B3E6D922, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000125/0000310764-20-000125-index.htm.","url":"https://asof.is/claim/clm_36F0B3E6D922","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"233,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_36F0B3E6D922","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2020, filed 2020-07-31"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 12,754,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_37F31BBBC6FC, https://asof.is/claim/clm_37F31BBBC6FC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000125/0000310764-20-000125-index.htm.","url":"https://asof.is/claim/clm_37F31BBBC6FC","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"12,754,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_37F31BBBC6FC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2020, filed 2020-07-31"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 6,539,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_632CC7E50B56, https://asof.is/claim/clm_632CC7E50B56, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000125/0000310764-20-000125-index.htm.","url":"https://asof.is/claim/clm_632CC7E50B56","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"6,539,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_632CC7E50B56","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2020, filed 2020-07-31"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: -83,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_7ED77DE92A80, https://asof.is/claim/clm_7ED77DE92A80, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000125/0000310764-20-000125-index.htm.","url":"https://asof.is/claim/clm_7ED77DE92A80","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"-83,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7ED77DE92A80","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2020, filed 2020-07-31"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 31,483,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_89CF1F66333D, https://asof.is/claim/clm_89CF1F66333D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000125/0000310764-20-000125-index.htm.","url":"https://asof.is/claim/clm_89CF1F66333D","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"31,483,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_89CF1F66333D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2020, filed 2020-07-31"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: -20,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_A04468B0236B, https://asof.is/claim/clm_A04468B0236B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000125/0000310764-20-000125-index.htm.","url":"https://asof.is/claim/clm_A04468B0236B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"-20,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A04468B0236B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2020, filed 2020-07-31"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 2,764,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_CA8B5A5A5010, https://asof.is/claim/clm_CA8B5A5A5010, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000125/0000310764-20-000125-index.htm.","url":"https://asof.is/claim/clm_CA8B5A5A5010","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"2,764,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CA8B5A5A5010","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2020, filed 2020-07-31"}},{"date":"2020-09-30","until":"2021-03-31","published":"2020-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 3,737,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_3A0C30A3001E, https://asof.is/claim/clm_3A0C30A3001E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000150/0000310764-20-000150-index.htm.","url":"https://asof.is/claim/clm_3A0C30A3001E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"3,737,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3A0C30A3001E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2020, filed 2020-10-30"}},{"date":"2020-09-30","until":"2021-03-31","published":"2020-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 242,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_3F1F450944DD, https://asof.is/claim/clm_3F1F450944DD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000150/0000310764-20-000150-index.htm.","url":"https://asof.is/claim/clm_3F1F450944DD","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"242,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3F1F450944DD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2020, filed 2020-10-30"}},{"date":"2020-09-30","until":"2021-01-31","published":"2020-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 375,790,657 shares\", as of 2020-09-30 (until 2021-01-31). Claim clm_4898674A017B, https://asof.is/claim/clm_4898674A017B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000150/0000310764-20-000150-index.htm.","url":"https://asof.is/claim/clm_4898674A017B","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"375,790,657 shares","status":"superseded","assertable":true,"id":"clm_4898674A017B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2020, filed 2020-10-30"}},{"date":"2020-09-30","until":"2020-12-31","published":"2020-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 32,286,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_6E1329A8D1B7, https://asof.is/claim/clm_6E1329A8D1B7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000150/0000310764-20-000150-index.htm.","url":"https://asof.is/claim/clm_6E1329A8D1B7","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"32,286,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6E1329A8D1B7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2020, filed 2020-10-30"}},{"date":"2020-09-30","until":"2020-12-31","published":"2020-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 7,083,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_6F14A1243C4C, https://asof.is/claim/clm_6F14A1243C4C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000150/0000310764-20-000150-index.htm.","url":"https://asof.is/claim/clm_6F14A1243C4C","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"7,083,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6F14A1243C4C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2020, filed 2020-10-30"}},{"date":"2020-09-30","until":"2021-03-31","published":"2020-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 621,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_9AFE611D64A6, https://asof.is/claim/clm_9AFE611D64A6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000150/0000310764-20-000150-index.htm.","url":"https://asof.is/claim/clm_9AFE611D64A6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"621,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9AFE611D64A6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2020, filed 2020-10-30"}},{"date":"2020-09-30","until":"2021-03-31","published":"2020-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 859,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_E3DDCD2831F6, https://asof.is/claim/clm_E3DDCD2831F6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000150/0000310764-20-000150-index.htm.","url":"https://asof.is/claim/clm_E3DDCD2831F6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"859,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E3DDCD2831F6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2020, filed 2020-10-30"}},{"date":"2020-09-30","until":"2020-12-31","published":"2020-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 12,986,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_FC13CCA118A9, https://asof.is/claim/clm_FC13CCA118A9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076420000150/0000310764-20-000150-index.htm.","url":"https://asof.is/claim/clm_FC13CCA118A9","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"12,986,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FC13CCA118A9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2020, filed 2020-10-30"}},{"date":"2020-12-31","until":"2021-03-31","published":"2021-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 34,330,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_1B7B53B5A4EF, https://asof.is/claim/clm_1B7B53B5A4EF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000027/0000310764-21-000027-index.htm.","url":"https://asof.is/claim/clm_1B7B53B5A4EF","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"34,330,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1B7B53B5A4EF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2020, filed 2021-02-11"}},{"date":"2020-12-31","until":"2021-03-31","published":"2021-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 13,084,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_33212DF52AA6, https://asof.is/claim/clm_33212DF52AA6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000027/0000310764-21-000027-index.htm.","url":"https://asof.is/claim/clm_33212DF52AA6","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"13,084,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_33212DF52AA6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2020, filed 2021-02-11"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 14,351,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_3FBD1E0D15C7, https://asof.is/claim/clm_3FBD1E0D15C7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000027/0000310764-21-000027-index.htm.","url":"https://asof.is/claim/clm_3FBD1E0D15C7","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"14,351,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3FBD1E0D15C7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2020, filed 2021-02-11"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 984,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_62B785D80A41, https://asof.is/claim/clm_62B785D80A41, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000027/0000310764-21-000027-index.htm.","url":"https://asof.is/claim/clm_62B785D80A41","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"984,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_62B785D80A41","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2020, filed 2021-02-11"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 1,599,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_7F3529364AEA, https://asof.is/claim/clm_7F3529364AEA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000027/0000310764-21-000027-index.htm.","url":"https://asof.is/claim/clm_7F3529364AEA","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"1,599,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7F3529364AEA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2020, filed 2021-02-11"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 2,223,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_B7F73D9673AD, https://asof.is/claim/clm_B7F73D9673AD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000027/0000310764-21-000027-index.htm.","url":"https://asof.is/claim/clm_B7F73D9673AD","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"2,223,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B7F73D9673AD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2020, filed 2021-02-11"}},{"date":"2020-12-31","until":"2021-03-31","published":"2021-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 2,943,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_E5289BAF04DB, https://asof.is/claim/clm_E5289BAF04DB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000027/0000310764-21-000027-index.htm.","url":"https://asof.is/claim/clm_E5289BAF04DB","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,943,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E5289BAF04DB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2020, filed 2021-02-11"}},{"date":"2021-01-31","until":"2021-03-31","published":"2021-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 376,200,942 shares\", as of 2021-01-31 (until 2021-03-31). Claim clm_41C99FB94D2C, https://asof.is/claim/clm_41C99FB94D2C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000027/0000310764-21-000027-index.htm.","url":"https://asof.is/claim/clm_41C99FB94D2C","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"376,200,942 shares","status":"superseded","assertable":true,"id":"clm_41C99FB94D2C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2020, filed 2021-02-11"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 13,502,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_0BCBBE47AAA3, https://asof.is/claim/clm_0BCBBE47AAA3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000065/0000310764-21-000065-index.htm.","url":"https://asof.is/claim/clm_0BCBBE47AAA3","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"13,502,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0BCBBE47AAA3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2021, filed 2021-04-28"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 3,953,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_0D4F61BB8188, https://asof.is/claim/clm_0D4F61BB8188, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000065/0000310764-21-000065-index.htm.","url":"https://asof.is/claim/clm_0D4F61BB8188","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"3,953,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0D4F61BB8188","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2021, filed 2021-04-28"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 33,455,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_54E13C0A5E37, https://asof.is/claim/clm_54E13C0A5E37, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000065/0000310764-21-000065-index.htm.","url":"https://asof.is/claim/clm_54E13C0A5E37","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"33,455,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_54E13C0A5E37","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2021, filed 2021-04-28"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 376,747,866 shares\", as of 2021-03-31 (until 2021-06-30). Claim clm_665DE2E83266, https://asof.is/claim/clm_665DE2E83266, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000065/0000310764-21-000065-index.htm.","url":"https://asof.is/claim/clm_665DE2E83266","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"376,747,866 shares","status":"superseded","assertable":true,"id":"clm_665DE2E83266","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2021, filed 2021-04-28"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 2,238,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_94B8F8D0E908, https://asof.is/claim/clm_94B8F8D0E908, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000065/0000310764-21-000065-index.htm.","url":"https://asof.is/claim/clm_94B8F8D0E908","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,238,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_94B8F8D0E908","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2021, filed 2021-04-28"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 288,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_BB226C7203CD, https://asof.is/claim/clm_BB226C7203CD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000065/0000310764-21-000065-index.htm.","url":"https://asof.is/claim/clm_BB226C7203CD","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"288,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BB226C7203CD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2021, filed 2021-04-28"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 459,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_C41FDE9399C1, https://asof.is/claim/clm_C41FDE9399C1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000065/0000310764-21-000065-index.htm.","url":"https://asof.is/claim/clm_C41FDE9399C1","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"459,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C41FDE9399C1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2021, filed 2021-04-28"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 302,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_DCEFD9F77D85, https://asof.is/claim/clm_DCEFD9F77D85, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000065/0000310764-21-000065-index.htm.","url":"https://asof.is/claim/clm_DCEFD9F77D85","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"302,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DCEFD9F77D85","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2021, filed 2021-04-28"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 310,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_1B41C91D3765, https://asof.is/claim/clm_1B41C91D3765, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000111/0000310764-21-000111-index.htm.","url":"https://asof.is/claim/clm_1B41C91D3765","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"310,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1B41C91D3765","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2021, filed 2021-07-28"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 4,294,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_49E3FDD42A5B, https://asof.is/claim/clm_49E3FDD42A5B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000111/0000310764-21-000111-index.htm.","url":"https://asof.is/claim/clm_49E3FDD42A5B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"4,294,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_49E3FDD42A5B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2021, filed 2021-07-28"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 33,698,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_8DE00F299F31, https://asof.is/claim/clm_8DE00F299F31, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000111/0000310764-21-000111-index.htm.","url":"https://asof.is/claim/clm_8DE00F299F31","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"33,698,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8DE00F299F31","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2021, filed 2021-07-28"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 732,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_997A8AB06997, https://asof.is/claim/clm_997A8AB06997, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000111/0000310764-21-000111-index.htm.","url":"https://asof.is/claim/clm_997A8AB06997","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"732,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_997A8AB06997","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2021, filed 2021-07-28"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 377,096,272 shares\", as of 2021-06-30 (until 2021-09-30). Claim clm_BB56BD93A9BF, https://asof.is/claim/clm_BB56BD93A9BF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000111/0000310764-21-000111-index.htm.","url":"https://asof.is/claim/clm_BB56BD93A9BF","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"377,096,272 shares","status":"superseded","assertable":true,"id":"clm_BB56BD93A9BF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2021, filed 2021-07-28"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 2,241,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_CA6DF06F86A9, https://asof.is/claim/clm_CA6DF06F86A9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000111/0000310764-21-000111-index.htm.","url":"https://asof.is/claim/clm_CA6DF06F86A9","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,241,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CA6DF06F86A9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2021, filed 2021-07-28"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 592,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_DF3088439F25, https://asof.is/claim/clm_DF3088439F25, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000111/0000310764-21-000111-index.htm.","url":"https://asof.is/claim/clm_DF3088439F25","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"592,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DF3088439F25","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2021, filed 2021-07-28"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 13,820,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_E294323D5A4D, https://asof.is/claim/clm_E294323D5A4D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000111/0000310764-21-000111-index.htm.","url":"https://asof.is/claim/clm_E294323D5A4D","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"13,820,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E294323D5A4D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2021, filed 2021-07-28"}},{"date":"2021-09-30","until":"2022-03-31","published":"2021-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 574,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_0FF8BA480AAF, https://asof.is/claim/clm_0FF8BA480AAF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000146/0000310764-21-000146-index.htm.","url":"https://asof.is/claim/clm_0FF8BA480AAF","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"574,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0FF8BA480AAF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2021, filed 2021-10-29"}},{"date":"2021-09-30","until":"2021-12-31","published":"2021-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 2,563,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_3120463C0611, https://asof.is/claim/clm_3120463C0611, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000146/0000310764-21-000146-index.htm.","url":"https://asof.is/claim/clm_3120463C0611","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,563,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3120463C0611","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2021, filed 2021-10-29"}},{"date":"2021-09-30","until":"2022-03-31","published":"2021-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 4,160,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_7B7FFAF7AEFF, https://asof.is/claim/clm_7B7FFAF7AEFF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000146/0000310764-21-000146-index.htm.","url":"https://asof.is/claim/clm_7B7FFAF7AEFF","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"4,160,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7B7FFAF7AEFF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2021, filed 2021-10-29"}},{"date":"2021-09-30","until":"2022-03-31","published":"2021-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 438,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_932E44B2A6E6, https://asof.is/claim/clm_932E44B2A6E6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000146/0000310764-21-000146-index.htm.","url":"https://asof.is/claim/clm_932E44B2A6E6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"438,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_932E44B2A6E6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2021, filed 2021-10-29"}},{"date":"2021-09-30","until":"2022-03-31","published":"2021-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 306,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_AE6D661B89B8, https://asof.is/claim/clm_AE6D661B89B8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000146/0000310764-21-000146-index.htm.","url":"https://asof.is/claim/clm_AE6D661B89B8","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"306,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AE6D661B89B8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2021, filed 2021-10-29"}},{"date":"2021-09-30","until":"2021-12-31","published":"2021-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 34,145,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_B4C1D863B831, https://asof.is/claim/clm_B4C1D863B831, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000146/0000310764-21-000146-index.htm.","url":"https://asof.is/claim/clm_B4C1D863B831","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"34,145,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B4C1D863B831","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2021, filed 2021-10-29"}},{"date":"2021-09-30","until":"2022-01-31","published":"2021-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 377,239,958 shares\", as of 2021-09-30 (until 2022-01-31). Claim clm_C42B98F1D35F, https://asof.is/claim/clm_C42B98F1D35F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000146/0000310764-21-000146-index.htm.","url":"https://asof.is/claim/clm_C42B98F1D35F","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"377,239,958 shares","status":"superseded","assertable":true,"id":"clm_C42B98F1D35F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2021, filed 2021-10-29"}},{"date":"2021-09-30","until":"2021-12-31","published":"2021-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 14,178,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_E19DAF1D43D2, https://asof.is/claim/clm_E19DAF1D43D2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076421000146/0000310764-21-000146-index.htm.","url":"https://asof.is/claim/clm_E19DAF1D43D2","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"14,178,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E19DAF1D43D2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2021, filed 2021-10-29"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 17,108,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_36118C63A661, https://asof.is/claim/clm_36118C63A661, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000028/0000310764-22-000028-index.htm.","url":"https://asof.is/claim/clm_36118C63A661","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"17,108,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_36118C63A661","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2021, filed 2022-02-11"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 1,994,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_432A4C4891BE, https://asof.is/claim/clm_432A4C4891BE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000028/0000310764-22-000028-index.htm.","url":"https://asof.is/claim/clm_432A4C4891BE","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"1,994,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_432A4C4891BE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2021, filed 2022-02-11"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 1,235,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_6DB75DA59E6C, https://asof.is/claim/clm_6DB75DA59E6C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000028/0000310764-22-000028-index.htm.","url":"https://asof.is/claim/clm_6DB75DA59E6C","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"1,235,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6DB75DA59E6C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2021, filed 2022-02-11"}},{"date":"2021-12-31","until":"2022-03-31","published":"2022-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 34,631,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_72263288A791, https://asof.is/claim/clm_72263288A791, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000028/0000310764-22-000028-index.htm.","url":"https://asof.is/claim/clm_72263288A791","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"34,631,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_72263288A791","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2021, filed 2022-02-11"}},{"date":"2021-12-31","until":"2022-03-31","published":"2022-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 2,944,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_80AF6CA9F612, https://asof.is/claim/clm_80AF6CA9F612, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000028/0000310764-22-000028-index.htm.","url":"https://asof.is/claim/clm_80AF6CA9F612","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,944,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_80AF6CA9F612","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2021, filed 2022-02-11"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 2,584,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_EA33BECE4B58, https://asof.is/claim/clm_EA33BECE4B58, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000028/0000310764-22-000028-index.htm.","url":"https://asof.is/claim/clm_EA33BECE4B58","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"2,584,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EA33BECE4B58","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2021, filed 2022-02-11"}},{"date":"2021-12-31","until":"2022-03-31","published":"2022-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 14,877,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_FC92F42FF040, https://asof.is/claim/clm_FC92F42FF040, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000028/0000310764-22-000028-index.htm.","url":"https://asof.is/claim/clm_FC92F42FF040","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"14,877,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FC92F42FF040","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2021, filed 2022-02-11"}},{"date":"2022-01-31","until":"2022-03-31","published":"2022-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 377,544,686 shares\", as of 2022-01-31 (until 2022-03-31). Claim clm_5569A0CF037F, https://asof.is/claim/clm_5569A0CF037F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000028/0000310764-22-000028-index.htm.","url":"https://asof.is/claim/clm_5569A0CF037F","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"377,544,686 shares","status":"superseded","assertable":true,"id":"clm_5569A0CF037F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2021, filed 2022-02-11"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 15,046,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_107B0DBB9181, https://asof.is/claim/clm_107B0DBB9181, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000062/0000310764-22-000062-index.htm.","url":"https://asof.is/claim/clm_107B0DBB9181","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"15,046,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_107B0DBB9181","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 4,275,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_5507D61C4249, https://asof.is/claim/clm_5507D61C4249, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000062/0000310764-22-000062-index.htm.","url":"https://asof.is/claim/clm_5507D61C4249","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"4,275,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5507D61C4249","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 36,137,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_68834141F7C1, https://asof.is/claim/clm_68834141F7C1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000062/0000310764-22-000062-index.htm.","url":"https://asof.is/claim/clm_68834141F7C1","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"36,137,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_68834141F7C1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 378,154,080 shares\", as of 2022-03-31 (until 2022-06-30). Claim clm_84C323772D25, https://asof.is/claim/clm_84C323772D25, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000062/0000310764-22-000062-index.htm.","url":"https://asof.is/claim/clm_84C323772D25","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"378,154,080 shares","status":"superseded","assertable":true,"id":"clm_84C323772D25","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 413,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_A39BDA39B027, https://asof.is/claim/clm_A39BDA39B027, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000062/0000310764-22-000062-index.htm.","url":"https://asof.is/claim/clm_A39BDA39B027","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"413,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A39BDA39B027","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,458,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_BC98327D4371, https://asof.is/claim/clm_BC98327D4371, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000062/0000310764-22-000062-index.htm.","url":"https://asof.is/claim/clm_BC98327D4371","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,458,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BC98327D4371","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 447,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_DEA1587275C0, https://asof.is/claim/clm_DEA1587275C0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000062/0000310764-22-000062-index.htm.","url":"https://asof.is/claim/clm_DEA1587275C0","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"447,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DEA1587275C0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 323,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_F3ABD9558B53, https://asof.is/claim/clm_F3ABD9558B53, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000062/0000310764-22-000062-index.htm.","url":"https://asof.is/claim/clm_F3ABD9558B53","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"323,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F3ABD9558B53","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 351,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_3F8F3E57B28D, https://asof.is/claim/clm_3F8F3E57B28D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000092/0000310764-22-000092-index.htm.","url":"https://asof.is/claim/clm_3F8F3E57B28D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"351,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3F8F3E57B28D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2022, filed 2022-07-27"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 656,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_80A3EFBCBAD6, https://asof.is/claim/clm_80A3EFBCBAD6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000092/0000310764-22-000092-index.htm.","url":"https://asof.is/claim/clm_80A3EFBCBAD6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"656,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_80A3EFBCBAD6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2022, filed 2022-07-27"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 4,493,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_8ADB9C2732AE, https://asof.is/claim/clm_8ADB9C2732AE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000092/0000310764-22-000092-index.htm.","url":"https://asof.is/claim/clm_8ADB9C2732AE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"4,493,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8ADB9C2732AE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2022, filed 2022-07-27"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 378,320,706 shares\", as of 2022-06-30 (until 2022-09-30). Claim clm_8F5C73E32769, https://asof.is/claim/clm_8F5C73E32769, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000092/0000310764-22-000092-index.htm.","url":"https://asof.is/claim/clm_8F5C73E32769","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"378,320,706 shares","status":"superseded","assertable":true,"id":"clm_8F5C73E32769","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2022, filed 2022-07-27"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,044,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_9935D2C8AC64, https://asof.is/claim/clm_9935D2C8AC64, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000092/0000310764-22-000092-index.htm.","url":"https://asof.is/claim/clm_9935D2C8AC64","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,044,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9935D2C8AC64","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2022, filed 2022-07-27"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 772,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_A7CDBD879370, https://asof.is/claim/clm_A7CDBD879370, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000092/0000310764-22-000092-index.htm.","url":"https://asof.is/claim/clm_A7CDBD879370","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"772,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A7CDBD879370","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2022, filed 2022-07-27"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 36,032,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_D70A27F0E17F, https://asof.is/claim/clm_D70A27F0E17F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000092/0000310764-22-000092-index.htm.","url":"https://asof.is/claim/clm_D70A27F0E17F","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"36,032,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D70A27F0E17F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2022, filed 2022-07-27"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-07-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 15,674,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_E30BE138D15F, https://asof.is/claim/clm_E30BE138D15F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000092/0000310764-22-000092-index.htm.","url":"https://asof.is/claim/clm_E30BE138D15F","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"15,674,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E30BE138D15F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2022, filed 2022-07-27"}},{"date":"2022-09-30","until":"2023-03-31","published":"2022-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 4,479,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_0CC54F791D54, https://asof.is/claim/clm_0CC54F791D54, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000105/0000310764-22-000105-index.htm.","url":"https://asof.is/claim/clm_0CC54F791D54","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"4,479,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0CC54F791D54","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2022, filed 2022-11-01"}},{"date":"2022-09-30","until":"2023-03-31","published":"2022-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 808,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_0F8973CB7A89, https://asof.is/claim/clm_0F8973CB7A89, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000105/0000310764-22-000105-index.htm.","url":"https://asof.is/claim/clm_0F8973CB7A89","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"808,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0F8973CB7A89","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2022, filed 2022-11-01"}},{"date":"2022-09-30","until":"2023-03-31","published":"2022-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 364,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_48C1FB0058DE, https://asof.is/claim/clm_48C1FB0058DE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000105/0000310764-22-000105-index.htm.","url":"https://asof.is/claim/clm_48C1FB0058DE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"364,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_48C1FB0058DE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2022, filed 2022-11-01"}},{"date":"2022-09-30","until":"2022-12-31","published":"2022-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 35,983,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_5313C6A9989F, https://asof.is/claim/clm_5313C6A9989F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000105/0000310764-22-000105-index.htm.","url":"https://asof.is/claim/clm_5313C6A9989F","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"35,983,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5313C6A9989F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2022, filed 2022-11-01"}},{"date":"2022-09-30","until":"2023-01-31","published":"2022-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 378,429,929 shares\", as of 2022-09-30 (until 2023-01-31). Claim clm_6291C6304B5B, https://asof.is/claim/clm_6291C6304B5B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000105/0000310764-22-000105-index.htm.","url":"https://asof.is/claim/clm_6291C6304B5B","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"378,429,929 shares","status":"superseded","assertable":true,"id":"clm_6291C6304B5B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2022, filed 2022-11-01"}},{"date":"2022-09-30","until":"2022-12-31","published":"2022-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 16,463,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_65F9A96B83C9, https://asof.is/claim/clm_65F9A96B83C9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000105/0000310764-22-000105-index.htm.","url":"https://asof.is/claim/clm_65F9A96B83C9","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"16,463,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_65F9A96B83C9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2022, filed 2022-11-01"}},{"date":"2022-09-30","until":"2023-03-31","published":"2022-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 816,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_73030729A6FA, https://asof.is/claim/clm_73030729A6FA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000105/0000310764-22-000105-index.htm.","url":"https://asof.is/claim/clm_73030729A6FA","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"816,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_73030729A6FA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2022, filed 2022-11-01"}},{"date":"2022-09-30","until":"2022-12-31","published":"2022-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,420,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_BDEBBBB013B2, https://asof.is/claim/clm_BDEBBBB013B2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076422000105/0000310764-22-000105-index.htm.","url":"https://asof.is/claim/clm_BDEBBBB013B2","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,420,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BDEBBBB013B2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2022, filed 2022-11-01"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 18,449,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_40407F60BA3F, https://asof.is/claim/clm_40407F60BA3F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000017/0000310764-23-000017-index.htm.","url":"https://asof.is/claim/clm_40407F60BA3F","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"18,449,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_40407F60BA3F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2022, filed 2023-02-10"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 2,841,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_4EE3A3B66706, https://asof.is/claim/clm_4EE3A3B66706, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000017/0000310764-23-000017-index.htm.","url":"https://asof.is/claim/clm_4EE3A3B66706","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"2,841,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4EE3A3B66706","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2022, filed 2023-02-10"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 2,358,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_4EEAAAAA1630, https://asof.is/claim/clm_4EEAAAAA1630, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000017/0000310764-23-000017-index.htm.","url":"https://asof.is/claim/clm_4EEAAAAA1630","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"2,358,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4EEAAAAA1630","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2022, filed 2023-02-10"}},{"date":"2022-12-31","until":"2023-03-31","published":"2023-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,844,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_5E3498F188C1, https://asof.is/claim/clm_5E3498F188C1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000017/0000310764-23-000017-index.htm.","url":"https://asof.is/claim/clm_5E3498F188C1","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,844,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5E3498F188C1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2022, filed 2023-02-10"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 1,454,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_BD2BED34F69F, https://asof.is/claim/clm_BD2BED34F69F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000017/0000310764-23-000017-index.htm.","url":"https://asof.is/claim/clm_BD2BED34F69F","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"1,454,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BD2BED34F69F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2022, filed 2023-02-10"}},{"date":"2022-12-31","until":"2023-03-31","published":"2023-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 16,616,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_EADAEE8199F9, https://asof.is/claim/clm_EADAEE8199F9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000017/0000310764-23-000017-index.htm.","url":"https://asof.is/claim/clm_EADAEE8199F9","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"16,616,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EADAEE8199F9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2022, filed 2023-02-10"}},{"date":"2022-12-31","until":"2023-03-31","published":"2023-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 36,884,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_FF47E396CE9D, https://asof.is/claim/clm_FF47E396CE9D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000017/0000310764-23-000017-index.htm.","url":"https://asof.is/claim/clm_FF47E396CE9D","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"36,884,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FF47E396CE9D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2022, filed 2023-02-10"}},{"date":"2023-01-01","until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation headquarters: Portage\", as of 2023-01-01. Claim clm_27F0F9E9DD75, https://asof.is/claim/clm_27F0F9E9DD75, accessed 2026-11-10. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000310764.","url":"https://asof.is/claim/clm_27F0F9E9DD75","accessed":"2026-11-10"},"kind":"other","predicate":"headquarters","value":"Portage","status":"valid","assertable":true,"id":"clm_27F0F9E9DD75","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":"2023-01-31","until":"2023-03-31","published":"2023-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 378,831,249 shares\", as of 2023-01-31 (until 2023-03-31). Claim clm_2FEC5DEE424B, https://asof.is/claim/clm_2FEC5DEE424B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000017/0000310764-23-000017-index.htm.","url":"https://asof.is/claim/clm_2FEC5DEE424B","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"378,831,249 shares","status":"superseded","assertable":true,"id":"clm_2FEC5DEE424B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2022, filed 2023-02-10"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 592,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_2ABE3E89FE3C, https://asof.is/claim/clm_2ABE3E89FE3C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000067/0000310764-23-000067-index.htm.","url":"https://asof.is/claim/clm_2ABE3E89FE3C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"592,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2ABE3E89FE3C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2023, filed 2023-05-02"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 16,895,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_458E880D987A, https://asof.is/claim/clm_458E880D987A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000067/0000310764-23-000067-index.htm.","url":"https://asof.is/claim/clm_458E880D987A","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"16,895,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_458E880D987A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2023, filed 2023-05-02"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,671,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_50097DFC71B2, https://asof.is/claim/clm_50097DFC71B2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000067/0000310764-23-000067-index.htm.","url":"https://asof.is/claim/clm_50097DFC71B2","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,671,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_50097DFC71B2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2023, filed 2023-05-02"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 4,778,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_620DA81F4D50, https://asof.is/claim/clm_620DA81F4D50, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000067/0000310764-23-000067-index.htm.","url":"https://asof.is/claim/clm_620DA81F4D50","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"4,778,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_620DA81F4D50","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2023, filed 2023-05-02"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 379,608,166 shares\", as of 2023-03-31 (until 2023-06-30). Claim clm_7F25DAFD7603, https://asof.is/claim/clm_7F25DAFD7603, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000067/0000310764-23-000067-index.htm.","url":"https://asof.is/claim/clm_7F25DAFD7603","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"379,608,166 shares","status":"superseded","assertable":true,"id":"clm_7F25DAFD7603","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2023, filed 2023-05-02"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 735,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_83888291EC11, https://asof.is/claim/clm_83888291EC11, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000067/0000310764-23-000067-index.htm.","url":"https://asof.is/claim/clm_83888291EC11","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"735,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_83888291EC11","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2023, filed 2023-05-02"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 36,830,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_A6EF509A5FCA, https://asof.is/claim/clm_A6EF509A5FCA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000067/0000310764-23-000067-index.htm.","url":"https://asof.is/claim/clm_A6EF509A5FCA","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"36,830,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A6EF509A5FCA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2023, filed 2023-05-02"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 339,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_E44F94D81C65, https://asof.is/claim/clm_E44F94D81C65, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000067/0000310764-23-000067-index.htm.","url":"https://asof.is/claim/clm_E44F94D81C65","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"339,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E44F94D81C65","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2023, filed 2023-05-02"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 738,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_4B846588B3B6, https://asof.is/claim/clm_4B846588B3B6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000106/0000310764-23-000106-index.htm.","url":"https://asof.is/claim/clm_4B846588B3B6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"738,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4B846588B3B6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2023, filed 2023-08-04"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 965,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_6752357B61EC, https://asof.is/claim/clm_6752357B61EC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000106/0000310764-23-000106-index.htm.","url":"https://asof.is/claim/clm_6752357B61EC","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"965,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6752357B61EC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2023, filed 2023-08-04"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 379,778,279 shares\", as of 2023-06-30 (until 2023-09-30). Claim clm_7347E897CAA6, https://asof.is/claim/clm_7347E897CAA6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000106/0000310764-23-000106-index.htm.","url":"https://asof.is/claim/clm_7347E897CAA6","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"379,778,279 shares","status":"superseded","assertable":true,"id":"clm_7347E897CAA6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2023, filed 2023-08-04"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 37,409,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_B2C741C020E2, https://asof.is/claim/clm_B2C741C020E2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000106/0000310764-23-000106-index.htm.","url":"https://asof.is/claim/clm_B2C741C020E2","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"37,409,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B2C741C020E2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2023, filed 2023-08-04"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 346,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_BE103908FA5C, https://asof.is/claim/clm_BE103908FA5C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000106/0000310764-23-000106-index.htm.","url":"https://asof.is/claim/clm_BE103908FA5C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"346,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BE103908FA5C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2023, filed 2023-08-04"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,401,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_E2474AE85325, https://asof.is/claim/clm_E2474AE85325, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000106/0000310764-23-000106-index.htm.","url":"https://asof.is/claim/clm_E2474AE85325","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,401,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E2474AE85325","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2023, filed 2023-08-04"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 4,996,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_E90C0FCB11CB, https://asof.is/claim/clm_E90C0FCB11CB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000106/0000310764-23-000106-index.htm.","url":"https://asof.is/claim/clm_E90C0FCB11CB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"4,996,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E90C0FCB11CB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2023, filed 2023-08-04"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 17,361,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_FB32E898682F, https://asof.is/claim/clm_FB32E898682F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000106/0000310764-23-000106-index.htm.","url":"https://asof.is/claim/clm_FB32E898682F","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"17,361,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FB32E898682F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2023, filed 2023-08-04"}},{"date":"2023-09-30","until":"2024-03-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 692,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_134D44728A08, https://asof.is/claim/clm_134D44728A08, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000116/0000310764-23-000116-index.htm.","url":"https://asof.is/claim/clm_134D44728A08","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"692,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_134D44728A08","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2023, filed 2023-11-03"}},{"date":"2023-09-30","until":"2024-03-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 353,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_16FF9A9D41FF, https://asof.is/claim/clm_16FF9A9D41FF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000116/0000310764-23-000116-index.htm.","url":"https://asof.is/claim/clm_16FF9A9D41FF","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"353,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_16FF9A9D41FF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2023, filed 2023-11-03"}},{"date":"2023-09-30","until":"2023-12-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 38,042,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_63C0089299CE, https://asof.is/claim/clm_63C0089299CE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000116/0000310764-23-000116-index.htm.","url":"https://asof.is/claim/clm_63C0089299CE","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"38,042,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_63C0089299CE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2023, filed 2023-11-03"}},{"date":"2023-09-30","until":"2024-03-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 4,909,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_6BB4A13B7973, https://asof.is/claim/clm_6BB4A13B7973, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000116/0000310764-23-000116-index.htm.","url":"https://asof.is/claim/clm_6BB4A13B7973","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"4,909,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6BB4A13B7973","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2023, filed 2023-11-03"}},{"date":"2023-09-30","until":"2024-03-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 931,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_73911C54E4C5, https://asof.is/claim/clm_73911C54E4C5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000116/0000310764-23-000116-index.htm.","url":"https://asof.is/claim/clm_73911C54E4C5","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"931,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_73911C54E4C5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2023, filed 2023-11-03"}},{"date":"2023-09-30","until":"2023-12-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,860,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_759592C24E7E, https://asof.is/claim/clm_759592C24E7E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000116/0000310764-23-000116-index.htm.","url":"https://asof.is/claim/clm_759592C24E7E","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,860,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_759592C24E7E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2023, filed 2023-11-03"}},{"date":"2023-09-30","until":"2023-12-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 17,905,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_FB65BB756D49, https://asof.is/claim/clm_FB65BB756D49, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000116/0000310764-23-000116-index.htm.","url":"https://asof.is/claim/clm_FB65BB756D49","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"17,905,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FB65BB756D49","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2023, filed 2023-11-03"}},{"date":"2023-09-30","until":"2024-01-31","published":"2023-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 379,894,650 shares\", as of 2023-09-30 (until 2024-01-31). Claim clm_FF73E3451A99, https://asof.is/claim/clm_FF73E3451A99, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076423000116/0000310764-23-000116-index.htm.","url":"https://asof.is/claim/clm_FF73E3451A99","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"379,894,650 shares","status":"superseded","assertable":true,"id":"clm_FF73E3451A99","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2023, filed 2023-11-03"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 1,388,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_356C61D74C38, https://asof.is/claim/clm_356C61D74C38, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000024/0000310764-24-000024-index.htm.","url":"https://asof.is/claim/clm_356C61D74C38","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"1,388,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_356C61D74C38","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2023, filed 2024-02-14"}},{"date":"2023-12-31","until":"2024-03-31","published":"2024-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 2,971,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_56B8F46418B7, https://asof.is/claim/clm_56B8F46418B7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000024/0000310764-24-000024-index.htm.","url":"https://asof.is/claim/clm_56B8F46418B7","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,971,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_56B8F46418B7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2023, filed 2024-02-14"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 3,165,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_A4432174E550, https://asof.is/claim/clm_A4432174E550, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000024/0000310764-24-000024-index.htm.","url":"https://asof.is/claim/clm_A4432174E550","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"3,165,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A4432174E550","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2023, filed 2024-02-14"}},{"date":"2023-12-31","until":"2024-03-31","published":"2024-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 18,593,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_B0598FAB3B66, https://asof.is/claim/clm_B0598FAB3B66, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000024/0000310764-24-000024-index.htm.","url":"https://asof.is/claim/clm_B0598FAB3B66","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"18,593,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B0598FAB3B66","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2023, filed 2024-02-14"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 3,888,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_BAFC137FE99D, https://asof.is/claim/clm_BAFC137FE99D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000024/0000310764-24-000024-index.htm.","url":"https://asof.is/claim/clm_BAFC137FE99D","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"3,888,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BAFC137FE99D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2023, filed 2024-02-14"}},{"date":"2023-12-31","until":"2024-03-31","published":"2024-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 39,912,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_BD268F9A723D, https://asof.is/claim/clm_BD268F9A723D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000024/0000310764-24-000024-index.htm.","url":"https://asof.is/claim/clm_BD268F9A723D","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"39,912,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BD268F9A723D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2023, filed 2024-02-14"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 20,498,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_C62E4500ABDC, https://asof.is/claim/clm_C62E4500ABDC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000024/0000310764-24-000024-index.htm.","url":"https://asof.is/claim/clm_C62E4500ABDC","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"20,498,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C62E4500ABDC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2023, filed 2024-02-14"}},{"date":"2024-01-31","until":"2024-03-31","published":"2024-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 380,264,036 shares\", as of 2024-01-31 (until 2024-03-31). Claim clm_7E342FF09D5C, https://asof.is/claim/clm_7E342FF09D5C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000024/0000310764-24-000024-index.htm.","url":"https://asof.is/claim/clm_7E342FF09D5C","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"380,264,036 shares","status":"superseded","assertable":true,"id":"clm_7E342FF09D5C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2023, filed 2024-02-14"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 972,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_0EC5837F2932, https://asof.is/claim/clm_0EC5837F2932, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000064/0000310764-24-000064-index.htm.","url":"https://asof.is/claim/clm_0EC5837F2932","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"972,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0EC5837F2932","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 5,243,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_4FCA84C9527C, https://asof.is/claim/clm_4FCA84C9527C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000064/0000310764-24-000064-index.htm.","url":"https://asof.is/claim/clm_4FCA84C9527C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"5,243,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4FCA84C9527C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 368,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_7C8827883B7B, https://asof.is/claim/clm_7C8827883B7B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000064/0000310764-24-000064-index.htm.","url":"https://asof.is/claim/clm_7C8827883B7B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"368,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7C8827883B7B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 380,949,778 shares\", as of 2024-03-31 (until 2024-06-30). Claim clm_AEBBBE0C8CC6, https://asof.is/claim/clm_AEBBBE0C8CC6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000064/0000310764-24-000064-index.htm.","url":"https://asof.is/claim/clm_AEBBBE0C8CC6","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"380,949,778 shares","status":"superseded","assertable":true,"id":"clm_AEBBBE0C8CC6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 2,330,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_C882425727AE, https://asof.is/claim/clm_C882425727AE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000064/0000310764-24-000064-index.htm.","url":"https://asof.is/claim/clm_C882425727AE","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,330,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C882425727AE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 788,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_DE9BF490C57B, https://asof.is/claim/clm_DE9BF490C57B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000064/0000310764-24-000064-index.htm.","url":"https://asof.is/claim/clm_DE9BF490C57B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"788,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DE9BF490C57B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 19,172,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_E780EF28D3DE, https://asof.is/claim/clm_E780EF28D3DE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000064/0000310764-24-000064-index.htm.","url":"https://asof.is/claim/clm_E780EF28D3DE","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"19,172,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E780EF28D3DE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 39,402,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_F25E74CC35B7, https://asof.is/claim/clm_F25E74CC35B7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000064/0000310764-24-000064-index.htm.","url":"https://asof.is/claim/clm_F25E74CC35B7","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"39,402,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F25E74CC35B7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 825,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_160857527ECA, https://asof.is/claim/clm_160857527ECA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000098/0000310764-24-000098-index.htm.","url":"https://asof.is/claim/clm_160857527ECA","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"825,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_160857527ECA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2024, filed 2024-07-31"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 381,075,364 shares\", as of 2024-06-30 (until 2024-09-30). Claim clm_2C64CA1A6809, https://asof.is/claim/clm_2C64CA1A6809, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000098/0000310764-24-000098-index.htm.","url":"https://asof.is/claim/clm_2C64CA1A6809","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"381,075,364 shares","status":"superseded","assertable":true,"id":"clm_2C64CA1A6809","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2024, filed 2024-07-31"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 39,130,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_30E8817B9D65, https://asof.is/claim/clm_30E8817B9D65, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000098/0000310764-24-000098-index.htm.","url":"https://asof.is/claim/clm_30E8817B9D65","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"39,130,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_30E8817B9D65","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2024, filed 2024-07-31"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 1,874,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_3279E14170A7, https://asof.is/claim/clm_3279E14170A7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000098/0000310764-24-000098-index.htm.","url":"https://asof.is/claim/clm_3279E14170A7","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,874,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3279E14170A7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2024, filed 2024-07-31"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 1,051,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_66DD8507F180, https://asof.is/claim/clm_66DD8507F180, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000098/0000310764-24-000098-index.htm.","url":"https://asof.is/claim/clm_66DD8507F180","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,051,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_66DD8507F180","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2024, filed 2024-07-31"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 19,762,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_7F8FFC97DB5D, https://asof.is/claim/clm_7F8FFC97DB5D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000098/0000310764-24-000098-index.htm.","url":"https://asof.is/claim/clm_7F8FFC97DB5D","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"19,762,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7F8FFC97DB5D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2024, filed 2024-07-31"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 5,422,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_92DA0A2215E9, https://asof.is/claim/clm_92DA0A2215E9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000098/0000310764-24-000098-index.htm.","url":"https://asof.is/claim/clm_92DA0A2215E9","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"5,422,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_92DA0A2215E9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2024, filed 2024-07-31"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 363,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_C535C15C7FA3, https://asof.is/claim/clm_C535C15C7FA3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000098/0000310764-24-000098-index.htm.","url":"https://asof.is/claim/clm_C535C15C7FA3","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"363,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C535C15C7FA3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2024, filed 2024-07-31"}},{"date":"2024-09-30","until":"2025-03-31","published":"2024-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 834,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_1F37CA2E62A9, https://asof.is/claim/clm_1F37CA2E62A9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000115/0000310764-24-000115-index.htm.","url":"https://asof.is/claim/clm_1F37CA2E62A9","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"834,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1F37CA2E62A9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2024, filed 2024-10-30"}},{"date":"2024-09-30","until":"2024-12-31","published":"2024-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 43,833,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_330E86BCCC8E, https://asof.is/claim/clm_330E86BCCC8E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000115/0000310764-24-000115-index.htm.","url":"https://asof.is/claim/clm_330E86BCCC8E","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"43,833,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_330E86BCCC8E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2024, filed 2024-10-30"}},{"date":"2024-09-30","until":"2024-12-31","published":"2024-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 20,149,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_63BF10208C6C, https://asof.is/claim/clm_63BF10208C6C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000115/0000310764-24-000115-index.htm.","url":"https://asof.is/claim/clm_63BF10208C6C","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"20,149,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_63BF10208C6C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2024, filed 2024-10-30"}},{"date":"2024-09-30","until":"2025-03-31","published":"2024-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 1,085,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_7E2205B81DC8, https://asof.is/claim/clm_7E2205B81DC8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000115/0000310764-24-000115-index.htm.","url":"https://asof.is/claim/clm_7E2205B81DC8","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,085,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7E2205B81DC8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2024, filed 2024-10-30"}},{"date":"2024-09-30","until":"2025-03-31","published":"2024-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 377,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_9E4B395BF18B, https://asof.is/claim/clm_9E4B395BF18B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000115/0000310764-24-000115-index.htm.","url":"https://asof.is/claim/clm_9E4B395BF18B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"377,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9E4B395BF18B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2024, filed 2024-10-30"}},{"date":"2024-09-30","until":"2024-12-31","published":"2024-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,850,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_9E7D2C63C45D, https://asof.is/claim/clm_9E7D2C63C45D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000115/0000310764-24-000115-index.htm.","url":"https://asof.is/claim/clm_9E7D2C63C45D","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,850,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9E7D2C63C45D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2024, filed 2024-10-30"}},{"date":"2024-09-30","until":"2025-03-31","published":"2024-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 5,494,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_B16FF22B9E44, https://asof.is/claim/clm_B16FF22B9E44, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000115/0000310764-24-000115-index.htm.","url":"https://asof.is/claim/clm_B16FF22B9E44","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"5,494,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B16FF22B9E44","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2024, filed 2024-10-30"}},{"date":"2024-09-30","until":"2025-01-31","published":"2024-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 381,215,773 shares\", as of 2024-09-30 (until 2025-01-31). Claim clm_B5A964A41635, https://asof.is/claim/clm_B5A964A41635, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076424000115/0000310764-24-000115-index.htm.","url":"https://asof.is/claim/clm_B5A964A41635","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"381,215,773 shares","status":"superseded","assertable":true,"id":"clm_B5A964A41635","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2024, filed 2024-10-30"}},{"date":"2024-12-31","until":"2025-03-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 20,634,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_12BE51995F1A, https://asof.is/claim/clm_12BE51995F1A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm.","url":"https://asof.is/claim/clm_12BE51995F1A","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"20,634,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_12BE51995F1A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 3,689,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_5442DF8B2745, https://asof.is/claim/clm_5442DF8B2745, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm.","url":"https://asof.is/claim/clm_5442DF8B2745","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"3,689,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5442DF8B2745","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 2,993,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_8D6AA07518A6, https://asof.is/claim/clm_8D6AA07518A6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm.","url":"https://asof.is/claim/clm_8D6AA07518A6","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"2,993,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8D6AA07518A6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-03-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 42,971,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_A908191DE631, https://asof.is/claim/clm_A908191DE631, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm.","url":"https://asof.is/claim/clm_A908191DE631","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"42,971,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A908191DE631","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 22,595,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_D8DB92A640FC, https://asof.is/claim/clm_D8DB92A640FC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm.","url":"https://asof.is/claim/clm_D8DB92A640FC","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"22,595,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D8DB92A640FC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 1,466,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_EC0F2D5205F4, https://asof.is/claim/clm_EC0F2D5205F4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm.","url":"https://asof.is/claim/clm_EC0F2D5205F4","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"1,466,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EC0F2D5205F4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-03-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,652,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_F02E8B934587, https://asof.is/claim/clm_F02E8B934587, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm.","url":"https://asof.is/claim/clm_F02E8B934587","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,652,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F02E8B934587","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2024, filed 2025-02-12"}},{"date":"2025-01-06","until":null,"published":"2025-01-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation agreement: Inari Medical, Inc.\", as of 2025-01-06. Claim clm_94085C3804FF, https://asof.is/claim/clm_94085C3804FF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312525002537/0001193125-25-002537-index.htm.","url":"https://asof.is/claim/clm_94085C3804FF","accessed":"2026-11-10"},"kind":"money","predicate":"agreement","value":"Inari Medical, Inc.","status":"valid","assertable":true,"id":"clm_94085C3804FF","evidence":{"by":"page-read","on":"2026-11-09","quote":"On January 6, 2025, Stryker Corporation, a Michigan corporation (“ Stryker ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), by and between Stryker and Inari Medical, Inc., a Delaware corporation (“ Inari ”).","url":"https://www.sec.gov/Archives/edgar/data/310764/000119312525002537/0001193125-25-002537-index.htm"}},{"date":"2025-01-31","until":"2025-03-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 381,579,123 shares\", as of 2025-01-31 (until 2025-03-31). Claim clm_70BB8F19F91A, https://asof.is/claim/clm_70BB8F19F91A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm.","url":"https://asof.is/claim/clm_70BB8F19F91A","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"381,579,123 shares","status":"superseded","assertable":true,"id":"clm_70BB8F19F91A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2024, filed 2025-02-12"}},{"date":"2025-02-19","until":null,"published":"2025-02-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation acquired: Inari Medical, Inc.\", as of 2025-02-19. Claim clm_DAABC8F362A5, https://asof.is/claim/clm_DAABC8F362A5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000119312525029187/0001193125-25-029187-index.htm.","url":"https://asof.is/claim/clm_DAABC8F362A5","accessed":"2026-11-10"},"kind":"money","predicate":"acquired","value":"Inari Medical, Inc.","status":"valid","assertable":true,"id":"clm_DAABC8F362A5","evidence":{"by":"page-read","on":"2026-11-09","quote":"On February 19, 2025, Stryker Corporation, a Michigan corporation (“Stryker”), and Eagle 1 Merger Sub, Inc., a Delaware corporation (“Merger Sub”) and a wholly owned subsidiary of Stryker, completed the acquisition of Inari Medical, Inc.","url":"https://www.sec.gov/Archives/edgar/data/310764/000119312525029187/0001193125-25-029187-index.htm"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 837,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_0644B8D40D3E, https://asof.is/claim/clm_0644B8D40D3E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000075/0000310764-25-000075-index.htm.","url":"https://asof.is/claim/clm_0644B8D40D3E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"837,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0644B8D40D3E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2025, filed 2025-05-02"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 382,164,865 shares\", as of 2025-03-31 (until 2025-06-30). Claim clm_09A7CDC507FF, https://asof.is/claim/clm_09A7CDC507FF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000075/0000310764-25-000075-index.htm.","url":"https://asof.is/claim/clm_09A7CDC507FF","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"382,164,865 shares","status":"superseded","assertable":true,"id":"clm_09A7CDC507FF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2025, filed 2025-05-02"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 405,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_7C5C7D59116D, https://asof.is/claim/clm_7C5C7D59116D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000075/0000310764-25-000075-index.htm.","url":"https://asof.is/claim/clm_7C5C7D59116D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"405,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7C5C7D59116D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2025, filed 2025-05-02"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 5,866,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_7E50B7B71F73, https://asof.is/claim/clm_7E50B7B71F73, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000075/0000310764-25-000075-index.htm.","url":"https://asof.is/claim/clm_7E50B7B71F73","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"5,866,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7E50B7B71F73","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2025, filed 2025-05-02"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 20,930,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_D106767DC80D, https://asof.is/claim/clm_D106767DC80D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000075/0000310764-25-000075-index.htm.","url":"https://asof.is/claim/clm_D106767DC80D","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"20,930,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D106767DC80D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2025, filed 2025-05-02"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 46,006,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_D3862E470779, https://asof.is/claim/clm_D3862E470779, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000075/0000310764-25-000075-index.htm.","url":"https://asof.is/claim/clm_D3862E470779","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"46,006,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D3862E470779","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2025, filed 2025-05-02"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 654,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_F4336F214A29, https://asof.is/claim/clm_F4336F214A29, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000075/0000310764-25-000075-index.htm.","url":"https://asof.is/claim/clm_F4336F214A29","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"654,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F4336F214A29","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2025, filed 2025-05-02"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 2,320,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_FAEBBC1425D0, https://asof.is/claim/clm_FAEBBC1425D0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000075/0000310764-25-000075-index.htm.","url":"https://asof.is/claim/clm_FAEBBC1425D0","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,320,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FAEBBC1425D0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2025, filed 2025-05-02"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 46,331,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_1870F1D404F5, https://asof.is/claim/clm_1870F1D404F5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000107/0000310764-25-000107-index.htm.","url":"https://asof.is/claim/clm_1870F1D404F5","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"46,331,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1870F1D404F5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2025, filed 2025-08-01"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 884,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_219472BC9759, https://asof.is/claim/clm_219472BC9759, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000107/0000310764-25-000107-index.htm.","url":"https://asof.is/claim/clm_219472BC9759","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"884,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_219472BC9759","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2025, filed 2025-08-01"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 1,113,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_5F5ED68B0ECB, https://asof.is/claim/clm_5F5ED68B0ECB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000107/0000310764-25-000107-index.htm.","url":"https://asof.is/claim/clm_5F5ED68B0ECB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,113,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5F5ED68B0ECB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2025, filed 2025-08-01"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 2,375,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_A6E16A5A3D39, https://asof.is/claim/clm_A6E16A5A3D39, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000107/0000310764-25-000107-index.htm.","url":"https://asof.is/claim/clm_A6E16A5A3D39","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,375,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A6E16A5A3D39","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2025, filed 2025-08-01"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 407,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_B39091391EB0, https://asof.is/claim/clm_B39091391EB0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000107/0000310764-25-000107-index.htm.","url":"https://asof.is/claim/clm_B39091391EB0","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"407,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B39091391EB0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2025, filed 2025-08-01"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 6,022,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_BA97FB0A4275, https://asof.is/claim/clm_BA97FB0A4275, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000107/0000310764-25-000107-index.htm.","url":"https://asof.is/claim/clm_BA97FB0A4275","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"6,022,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BA97FB0A4275","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2025, filed 2025-08-01"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 382,307,298 shares\", as of 2025-06-30 (until 2025-09-30). Claim clm_EDD77685BC04, https://asof.is/claim/clm_EDD77685BC04, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000107/0000310764-25-000107-index.htm.","url":"https://asof.is/claim/clm_EDD77685BC04","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"382,307,298 shares","status":"superseded","assertable":true,"id":"clm_EDD77685BC04","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2025, filed 2025-08-01"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 21,191,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_EE223BA502CD, https://asof.is/claim/clm_EE223BA502CD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000107/0000310764-25-000107-index.htm.","url":"https://asof.is/claim/clm_EE223BA502CD","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"21,191,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EE223BA502CD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2025, filed 2025-08-01"}},{"date":"2025-09-30","until":"2025-12-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 47,057,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_1B2097560390, https://asof.is/claim/clm_1B2097560390, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_1B2097560390","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"47,057,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1B2097560390","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-10-31"}},{"date":"2025-09-30","until":"2025-12-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,256,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_3DD0AACD5492, https://asof.is/claim/clm_3DD0AACD5492, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_3DD0AACD5492","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,256,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3DD0AACD5492","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-10-31"}},{"date":"2025-09-30","until":"2026-01-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 382,423,648 shares\", as of 2025-09-30 (until 2026-01-31). Claim clm_53217597F2B0, https://asof.is/claim/clm_53217597F2B0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_53217597F2B0","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"382,423,648 shares","status":"superseded","assertable":true,"id":"clm_53217597F2B0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-10-31"}},{"date":"2025-09-30","until":"2025-12-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 21,785,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_5C2DB82E169E, https://asof.is/claim/clm_5C2DB82E169E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_5C2DB82E169E","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"21,785,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5C2DB82E169E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2025, filed 2025-10-31"}},{"date":"2025-09-30","until":"2026-03-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 410,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_840CBFF64E83, https://asof.is/claim/clm_840CBFF64E83, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_840CBFF64E83","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"410,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_840CBFF64E83","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2025, filed 2025-10-31"}},{"date":"2025-09-30","until":"2026-03-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 6,057,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_8E877412AAEE, https://asof.is/claim/clm_8E877412AAEE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_8E877412AAEE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"6,057,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8E877412AAEE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2025, filed 2025-10-31"}},{"date":"2025-09-30","until":"2026-03-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 1,135,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_B72036341823, https://asof.is/claim/clm_B72036341823, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_B72036341823","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,135,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B72036341823","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-31"}},{"date":"2025-09-30","until":"2026-03-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 859,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_D8A0D107B7F6, https://asof.is/claim/clm_D8A0D107B7F6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_D8A0D107B7F6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"859,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D8A0D107B7F6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-31"}},{"date":"2025-12-31","until":"2026-03-31","published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 4,011,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_01F1E3D2AFA5, https://asof.is/claim/clm_01F1E3D2AFA5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm.","url":"https://asof.is/claim/clm_01F1E3D2AFA5","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"4,011,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_01F1E3D2AFA5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-31","until":"2026-03-31","published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 47,844,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_1C3EDF939FE8, https://asof.is/claim/clm_1C3EDF939FE8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm.","url":"https://asof.is/claim/clm_1C3EDF939FE8","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"47,844,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1C3EDF939FE8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-31","until":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 25,116,000,000 United States dollar\", as of 2025-12-31. Claim clm_2711436885CB, https://asof.is/claim/clm_2711436885CB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm.","url":"https://asof.is/claim/clm_2711436885CB","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"25,116,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_2711436885CB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-31","until":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 4,889,000,000 United States dollar\", as of 2025-12-31. Claim clm_57564F6F4242, https://asof.is/claim/clm_57564F6F4242, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm.","url":"https://asof.is/claim/clm_57564F6F4242","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"4,889,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_57564F6F4242","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-31","until":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 3,246,000,000 United States dollar\", as of 2025-12-31. Claim clm_67A3BD4DA5CA, https://asof.is/claim/clm_67A3BD4DA5CA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm.","url":"https://asof.is/claim/clm_67A3BD4DA5CA","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"3,246,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_67A3BD4DA5CA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-31","until":"2026-03-31","published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 22,420,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_6E60905B1047, https://asof.is/claim/clm_6E60905B1047, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm.","url":"https://asof.is/claim/clm_6E60905B1047","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"22,420,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6E60905B1047","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-31","until":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 1,623,000,000 United States dollar\", as of 2025-12-31. Claim clm_DAC9135A26A9, https://asof.is/claim/clm_DAC9135A26A9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm.","url":"https://asof.is/claim/clm_DAC9135A26A9","accessed":"2026-11-10"},"kind":"money","predicate":"research_and_development","value":"1,623,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_DAC9135A26A9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2025, filed 2026-02-11"}},{"date":"2026-01-31","until":"2026-03-31","published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 382,688,675 shares\", as of 2026-01-31 (until 2026-03-31). Claim clm_E8EFDF649C1E, https://asof.is/claim/clm_E8EFDF649C1E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm.","url":"https://asof.is/claim/clm_E8EFDF649C1E","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"382,688,675 shares","status":"superseded","assertable":true,"id":"clm_E8EFDF649C1E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2025, filed 2026-02-11"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 413,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_0B263C3D2C56, https://asof.is/claim/clm_0B263C3D2C56, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000031/0000310764-26-000031-index.htm.","url":"https://asof.is/claim/clm_0B263C3D2C56","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"413,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0B263C3D2C56","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2026, filed 2026-05-11"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 6,020,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_14534DCC89AD, https://asof.is/claim/clm_14534DCC89AD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000031/0000310764-26-000031-index.htm.","url":"https://asof.is/claim/clm_14534DCC89AD","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"6,020,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_14534DCC89AD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2026, filed 2026-05-11"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 383,360,762 shares\", as of 2026-03-31 (until 2026-06-30). Claim clm_2452BE201213, https://asof.is/claim/clm_2452BE201213, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000031/0000310764-26-000031-index.htm.","url":"https://asof.is/claim/clm_2452BE201213","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"383,360,762 shares","status":"superseded","assertable":true,"id":"clm_2452BE201213","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2026, filed 2026-05-11"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 46,291,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_62C4C7E7F9B5, https://asof.is/claim/clm_62C4C7E7F9B5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000031/0000310764-26-000031-index.htm.","url":"https://asof.is/claim/clm_62C4C7E7F9B5","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"46,291,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_62C4C7E7F9B5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2026, filed 2026-05-11"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 2,878,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_985B3538CAF1, https://asof.is/claim/clm_985B3538CAF1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000031/0000310764-26-000031-index.htm.","url":"https://asof.is/claim/clm_985B3538CAF1","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,878,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_985B3538CAF1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2026, filed 2026-05-11"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 745,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_E3E05BB77AD2, https://asof.is/claim/clm_E3E05BB77AD2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000031/0000310764-26-000031-index.htm.","url":"https://asof.is/claim/clm_E3E05BB77AD2","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"745,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E3E05BB77AD2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2026, filed 2026-05-11"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 936,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_F2E70133269B, https://asof.is/claim/clm_F2E70133269B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000031/0000310764-26-000031-index.htm.","url":"https://asof.is/claim/clm_F2E70133269B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"936,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F2E70133269B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2026, filed 2026-05-11"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 22,979,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_F4FB345DC757, https://asof.is/claim/clm_F4FB345DC757, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000031/0000310764-26-000031-index.htm.","url":"https://asof.is/claim/clm_F4FB345DC757","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"22,979,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F4FB345DC757","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2026, filed 2026-05-11"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 1,659,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_01CBABA1BBEB, https://asof.is/claim/clm_01CBABA1BBEB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000050/0000310764-26-000050-index.htm.","url":"https://asof.is/claim/clm_01CBABA1BBEB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,659,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_01CBABA1BBEB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2026, filed 2026-07-31"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 47,930,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_1DEE2C9335E3, https://asof.is/claim/clm_1DEE2C9335E3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000050/0000310764-26-000050-index.htm.","url":"https://asof.is/claim/clm_1DEE2C9335E3","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"47,930,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1DEE2C9335E3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2026, filed 2026-07-31"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 1,276,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_4D0E87EFBB8C, https://asof.is/claim/clm_4D0E87EFBB8C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000050/0000310764-26-000050-index.htm.","url":"https://asof.is/claim/clm_4D0E87EFBB8C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,276,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4D0E87EFBB8C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2026, filed 2026-07-31"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 434,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_7BA4911CD0D8, https://asof.is/claim/clm_7BA4911CD0D8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000050/0000310764-26-000050-index.htm.","url":"https://asof.is/claim/clm_7BA4911CD0D8","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"434,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7BA4911CD0D8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2026, filed 2026-07-31"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,391,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_7EDF7EEA8C6F, https://asof.is/claim/clm_7EDF7EEA8C6F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000050/0000310764-26-000050-index.htm.","url":"https://asof.is/claim/clm_7EDF7EEA8C6F","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,391,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7EDF7EEA8C6F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2026, filed 2026-07-31"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 6,589,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_81C6EB299F23, https://asof.is/claim/clm_81C6EB299F23, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000050/0000310764-26-000050-index.htm.","url":"https://asof.is/claim/clm_81C6EB299F23","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"6,589,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_81C6EB299F23","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2026, filed 2026-07-31"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 23,988,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_879576B2DBD5, https://asof.is/claim/clm_879576B2DBD5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000050/0000310764-26-000050-index.htm.","url":"https://asof.is/claim/clm_879576B2DBD5","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"23,988,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_879576B2DBD5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2026, filed 2026-07-31"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 383,573,046 shares\", as of 2026-06-30 (until 2026-09-30). Claim clm_AF7B38A6E983, https://asof.is/claim/clm_AF7B38A6E983, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000050/0000310764-26-000050-index.htm.","url":"https://asof.is/claim/clm_AF7B38A6E983","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"383,573,046 shares","status":"superseded","assertable":true,"id":"clm_AF7B38A6E983","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2026, filed 2026-07-31"}},{"date":"2026-09-30","until":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,271,000,000 United States dollar\", as of 2026-09-30. Claim clm_081F1213F18C, https://asof.is/claim/clm_081F1213F18C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_081F1213F18C","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,271,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_081F1213F18C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-10-30"}},{"date":"2026-09-30","until":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 6,520,000,000 United States dollar\", as of 2026-09-30. Claim clm_08A9619123F8, https://asof.is/claim/clm_08A9619123F8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_08A9619123F8","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"6,520,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_08A9619123F8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2026, filed 2026-10-30"}},{"date":"2026-09-30","until":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 380,691,004 shares\", as of 2026-09-30. Claim clm_2175673D8B90, https://asof.is/claim/clm_2175673D8B90, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_2175673D8B90","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"380,691,004 shares","status":"valid","assertable":true,"id":"clm_2175673D8B90","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-10-30"}},{"date":"2026-09-30","until":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 753,000,000 United States dollar\", as of 2026-09-30. Claim clm_35B4FBD845E2, https://asof.is/claim/clm_35B4FBD845E2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_35B4FBD845E2","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"753,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_35B4FBD845E2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-10-30"}},{"date":"2026-09-30","until":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 23,457,000,000 United States dollar\", as of 2026-09-30. Claim clm_7FA8580013B6, https://asof.is/claim/clm_7FA8580013B6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_7FA8580013B6","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"23,457,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_7FA8580013B6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2026, filed 2026-10-30"}},{"date":"2026-09-30","until":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 433,000,000 United States dollar\", as of 2026-09-30. Claim clm_9A4F807637F2, https://asof.is/claim/clm_9A4F807637F2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_9A4F807637F2","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_research_and_development","value":"433,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_9A4F807637F2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2026, filed 2026-10-30"}},{"date":"2026-09-30","until":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 1,034,000,000 United States dollar\", as of 2026-09-30. Claim clm_AE0E97F1AC79, https://asof.is/claim/clm_AE0E97F1AC79, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_AE0E97F1AC79","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,034,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_AE0E97F1AC79","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2026, filed 2026-10-30"}},{"date":"2026-09-30","until":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 47,247,000,000 United States dollar\", as of 2026-09-30. Claim clm_B99FA67BFA76, https://asof.is/claim/clm_B99FA67BFA76, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_B99FA67BFA76","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"47,247,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_B99FA67BFA76","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-10-30"}}],"complete":true,"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{"low_confidence":"Confidence below 0.5, the line the record asserts at."},"checked_by":{"sec-filing":"parsed from the SEC filing","page-read":"its source page states the value and the date","own-site":"the entity's own site names it (a website whose page names the entity, a handle its website links to)"}}}